,brand_name,ATC_A,ATC_B,ATC_C,ATC_D,ATC_G,ATC_H,ATC_J,ATC_L,ATC_M,ATC_N,ATC_P,ATC_R,ATC_S,ATC_V,description,company,condition,dates_clean,approval_date,generic_name,Biosimilar or new formulation?,total_pts_rct,txt_pts_rct,placebo_pts_rct,comparator_pts_rct,NCTid_1,NCTid_2,NCTid_3,NCTid_4,NCTid_5,NCTid_6,,1,ubrelvy,,,,,,,,,,TRUE,,,,,"Ubrelvy (ubrogepant) is a potent, orally-administered CGRP receptor antagonist for the acute treatment of migraine.",Allergan plc,Migraine,23-Dec-19,12/23/19,ubrogepant,No,2797,1675,1122,0,NCT02828020,NCT02867709,,,,,,1,caplyta,,,,,,,,,,TRUE,,,,,Caplyta (lumateperone) is first-in-class antipsychotic for the treatment of schizophrenia.,"Intra-Cellular Therapies, Inc.",Schizophrenia,23-Dec-19,12/23/19,lumateperone,No,469,234,235,0,NCT01499563,NCT02282761,,,,,,1,enhertu,,,,,,,,TRUE,,,,,,,Enhertu (fam-trastuzumab deruxtecan-nxki) is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting.,"AstraZeneca and Daiichi Sankyo Company, Limited",Breast Cancer,20-Dec-19,12/20/19,fam,No,184,184,0,0,NCT03248492,,,,,,,1,dayvigo,,,,,,,,,,TRUE,,,,,Dayvigo (lemborexant) is dual orexin receptor antagonist (DORA) for the treatment of insomnia.,"Eisai Co., Ltd.",Insomnia,20-Dec-19,12/20/19,lemborexant,No,1714,1181,533,0,NCT02952820,NCT02783729,,,,,,1,Padcev,,,,,,,,TRUE,,,,,,,Padcev (enfortumab vedotin-ejfv) is a Nectin-4 targeted antibody-drug conjugate (ADC) for the treatment of patients with locally advanced or metastatic urothelial cancer.,Astellas Pharma Inc.,Urothelial Carcinoma,18-Dec-19,12/18/19,enfortumab vedotin-ejfv,No,125,125,0,0,NCT0321933,,,,,,,1,Aralzo,,,,TRUE,,,,,,,,,,,Arazlo (tazarotene) is a lotion formulation of the approved retinoid tazarotene for the topical treatment of acne vulgaris in patients 9 years of age and older.,Bausch Health Companies Inc.,Acne,18-Dec-19,12/18/19,tazarotene,No,1614,799,815,0,NCT03168321,NCT03168334,,,,,,1,Vyondys 53,,,,,,,,,TRUE,,,,,,Vyondys 53 (golodirsen) is a phosphordiamidate morpholino oligimer for the treatment of Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation amenable to exon 53 skipping.,"Sarepta Therapeutics, Inc.",Duchenne Muscular Dystrophy,12-Dec-19,12/12/19,golodirsen,No,25,25,0,0,NCT02310906,,,,,,,1,Oxbryta,,TRUE,,,,,,,,,,,,,"Oxbryta (voxelotor) is an oral, HbS (sickle hemoglobin) polymerization inhibitor for the treatment of patients with sickle cell disease (SCD).","Global Blood Therapeutics, Inc.",Sickle Cell Anemia,25-Nov-19,11/25/19,voxelotor,No,182,91,91,0,NCT03036813,,,,,,,1,Xcopri,,,,,,,,,,TRUE,,,,,Xcopri (cenobamate) is an antiepileptic drug for the treatment of partial-onset seizures in adult patients.,"SK Life Science, Inc.",Seizures,21-Nov-19,11/21/19,cenobamate,No,655,441,214,0,NCT01866111,NCT01397968,,,,,,1,Givlaari,TRUE,,,,,,,,,,,,,,Givlaari (givosiran) is an aminolevulinate synthase 1-directed small interfering RNA (siRNA) indicated for the treatment of adults with acute hepatic porphyria (AHP).,"Alnylam Pharmaceuticals, Inc.",Acute Hepatic Porphyria,20-Nov-19,11/20/19,givosiran,No,94,48,46,0,NCT03338816,,,,,,,1,Adakveo,,TRUE,,,,,,,,,,,,,Adakveo (crizanlizumab-tmca) is a P-selectin inhibitor for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD).,Novartis,Prevention of Vaso-Occlusive Crises (VOCs) in Sickle Cell Disease,15-Nov-19,11/15/19,crizanlizumab-tmca,No,198,133,65,0,NCT01895361,,,,,,,1,Brukinsa,,,,,,,,TRUE,,,,,,,Brukinsa (zanubrutinib) is a Bruton's tyrosine kinase (BTK) inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.,"BeiGene, Ltd.",Mantle Cell Lymphoma,14-Nov-19,11/14/19,zanubrutinib,No,118,118,0,0,NCT03206970,NCT02343120,,,,,,1,Fetroja,,,,,,,TRUE,,,,,,,,Fetroja (cefiderocol) is a siderophore cephalosporin indicated for the treatment of complicated urinary tract infections (cUTI) in patients with limited or no alternative treatment options.,"Shionogi & Co., Ltd.",Complicated Urinary Tract Infections,14-Nov-19,11/14/19,cefiderocol,No,448,300,0,148,NCT02321800,,,,,,,1,Reblozyl,,TRUE,,,,,,,,,,,,,Reblozyl (luspatercept-aamt) is a first-in-class erythroid maturation agent (EMA) for the treatment of transfusion-dependent beta-thalassemia-associated anemia.,Celgene Corporation,Beta-Thalassemia-Associated Anemia,8-Nov-19,11/8/19,luspatercept-aamt,No,336,224,112,0,NCT02604433,,,,,,,1,Trikafta,,,,,,,,,,,,TRUE,,,Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) is a triple combination regimen for the treatment of cystic fibrosis (CF) in patients ages 12 years and older who have at least one copy of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.,Vertex Pharmaceuticals Incorporated,Cystic Fibrosis,21-Oct-19,10/21/19,elexacaftor/tezacaftor/ivacaftor and ivacaftor,No,510,255,203,52,NCT03525444,NCT03525548,,,,,,1,Reyvow,,,,,,,,,,TRUE,,,,,Reyvow (lasmiditan) is a serotonin (5-HT)1F receptor agonist indicated for the acute treatment of migraine with or without aura in adults.,Eli Lilly and Company,Migraine,11-Oct-19,10/11/19,lasmiditan,No,4439,3177,1262,0,NCT02439320,NCT02605174,,,,,,1,Scenesse,,,,TRUE,,,,,,,,,,,Scenesse (afamelanotide) is a selective agonist of the melanocortin 1 receptor (MC1R) indicated for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).,Clinuvel Pharmaceuticals Ltd.,Prevention of Phototoxicity in Erythropoietic Protoporphyria,8-Oct-19,10/8/19,afamelanotide,No,167,86,81,0,NCT01605136,NCT00979745,,,,,,1,Beovu,,,,,,,,,,,,,TRUE,,Beovu (brolucizumab-dbll) is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD).,Novartis,Macular Degeneration,7-Oct-19,10/7/19,brolucizumab-dbll,No,1459,730,729,0,NCT02307682,NCT02434328,,,,,,1,Aklief,,,,TRUE,,,,,,,,,,,Aklief (trifarotene) is a topical retinoid indicated for the treatment of acne vulgaris in patients 9 years of age and older.,Galderma,Acne,4-Oct-19,10/4/19,trifarotene,No,2420,1214,1206,0,NCT02566369,NCT02556788,,,,,,1,Ibsrela,TRUE,,,,,,,,,,,,,,"Ibsrela (tenapanor) is a first-in-class, sodium/hydrogen exchanger 3 (NHE3) inhibitor indicated for the treatment of adults with irritable bowel syndrome with constipation (IBS-C).","Ardelyx, Inc",Irritable Bowel Syndrome,12-Sep-19,9/12/19,tenapanor,No,1199,600,599,0,NCT02686138,NCT02621892,,,,,,1,Nourianz,,,,,,,,,,TRUE,,,,,Nourianz (istradefylline) is an adenosine A2A receptor antagonist indicated for use as an adjunctive treatment to levodopa/carbidopa in adult patients with Parkinsonäó»s disease (PD) experiencing äóìOFFäó episodes.,"Kyowa Kirin, Inc.",Parkinson's Disease,27-Aug-19,8/27/19,istradefylline,No,1143,723,420,0,NCT00456586,NCT00199407,NCT00455507,NCT00955526,,,,1,Xenleta,,,,,,,TRUE,,,,,,,,"Xenleta (lefamulin) is a first-in-class, semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia (CABP).",Nabriva Therapeutics plc,Pneumonia,19-Aug-19,8/19/19,lefamulin,No,1289,646,0,643,NCT02559310,NCT02813694,,,,,,1,Rinvoq,,,,,,,,TRUE,,,,,,,Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor for the treatment of adult patients with moderate to severe rheumatoid arthritis.,AbbVie Inc.,Rheumatoid Arthritis,16-Aug-19,8/16/19,upadacitinib,No,3141,1570,1041,530,NCT02706873,NCT02706951,NCT02675426,NCT02629159,NCT02706847,,,1,Inrebic,,,,,,,,TRUE,,,,,,,Inrebic (fedratinib) is a highly selective JAK2 inhibitor for the treatment of patients with myelofibrosis.,Celgene Corporation,Myelofibrosis,16-Aug-19,8/16/19,fedratinib,No,289,193,96,0,NCT01437787,,,,,,,1,Rozlytrek,,,,,,,,TRUE,,,,,,,"Rozlytrek (entrectinib) is a selective tyrosine kinase inhibitor for the treatment of patients with ROS1-positive, metastatic non-small cell lung cancer and neurotrophic tyrosine receptor kinase (NTRK) gene fusion-positive solid tumors.","Genentech, Inc.","Solid Tumors, Non-Small Cell Lung Cancer",15-Aug-19,8/15/19,entrectinib,No,54,54,0,0,NCT02097810,NCT02568267,EudraCT 2012-000148-88æ,,,,,1,Wakix,,,,,,,,,,TRUE,,,,,Wakix (pitolisant) is a histamine-3 (Hä‰€) receptor antagonist/inverse agonist for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.,"Harmony Biosciences, LLC",Narcolepsy,14-Aug-19,8/14/19,pitolisant,No,159,97,62,0,NCT01067222,NCT01638403,,,,,,1,pretomanid,,,,,,,TRUE,,,,,,,,"Pretomanid is a nitroimidazooxazine antimycobacterial indicated for use in combination with bedaquiline and linezolid (the BPaL regimen) for the treatment of adults with pulmonary extensively drug resistant (XDR), treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB).",TB Alliance,Tuberculosis -- Resistant,14-Aug-19,8/14/19,pretomanid,No,107,107,0,0,NCT02333799,,,,,,,1,Turalio,,,,,,,,TRUE,,,,,,,Turalio (pexidartinib) is a kinase inhibitor indicated for the treatment of symptomatic tenosynovial giant cell tumor (TGCT) in adults.,"Daiichi Sankyo Company, Limited",Tenosynovial Giant Cell Tumor,2-Aug-19,8/2/19,pexidartinib,No,120,61,59,0,NCT02371369,,,,,,,1,Nubeqa,,,,,,,,TRUE,,,,,,,Nubeqa (darolutamide) is an androgen receptor inhibitor (ARi) indicated for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC).,Bayer,Prostate Cancer,30-Jul-19,7/30/19,darolutamide,No,1509,955,554,0,NCT02200614,,,,,,,1,Accrufer,,TRUE,,,,,,,,,,,,,Accrufer (ferric maltol) is a non-salt formulation of ferric iron for the treatment of iron deficiency in adults.,Shield Therapeutics plc,Iron Deficiency,25-Jul-19,7/25/19,ferric maltol,No,295,175,120,0,NCT01252221,NCT01340872,NCT02968368,,,,,1,Recarbrio,,,,,,,TRUE,,,,,,,,"Recarbrio (imipenem, cilastatin, and relebactam) is a combination of imipenem, a penem antibacterial, cilastatin, a renal dehydropeptidase inhibitor, and relebactam, a betalactamase inhibitor, indicated for the treatment of complicated urinary tract infections and complicated intra-abdominal infections (cIAI).",Merck,"Urinary Tract Infection, Intraabdominal Infection",16-Jul-19,7/16/19,"imipenem, cilastatin, and relebactam",No,0,0,0,0,The contribution of relebactam to RECARBRIO was primarily established in vitro and in animal models of infection,,,,,,,1,Xpovio,,,,,,,,TRUE,,,,,,,Xpovio (selinexor) is a first in class Selective Inhibitor of Nuclear Export (SINE) XPO1 antagonist for the treatment of patients adult patients with relapsed or refractory multiple myeloma (RRMM).,Karyopharm Therapeutics Inc.,Multiple Myeloma,3-Jul-19,7/3/19,selinexor,No,83,83,0,0,NCT02336815,,,,,,,1,Vyleesi,,,,,TRUE,,,,,,,,,,Vyleesi  (bremelanotide) is a melanocortin receptor agonist for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.,"AMAG Pharmaceuticals, Inc.",Hypoactive Sexual Desire Disorder,21-Jun-19,6/21/19,bremelanotide,No,1198,595,603,0,NCT02333071,NCT02338960,,,,,,1,Polivy,,,,,,,,TRUE,,,,,,,"Polivy (polatuzumab vedotin-piiq) is a CD79b-directed antibody drug conjugate indicated in combination with bendamustine and rituximab for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma, who have received at least two prior therapies.","Genentech, Inc.",Diffuse Large B-Cell Lymphoma,10-Jun-19,6/10/19,polatuzumab vedotin-piiq,No,80,40,0,40,NCT02257567,,,,,,,1,Piqray,,,,,,,,TRUE,,,,,,,"Piqray (alpelisib) is a kinase inhibitor indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with HR positive, HER2-negative, PIK3CA-mutated breast cancer.",Novartis,Breast Cancer,24-May-19,5/24/19,alpelisib,No,341,169,172,0,NCT02437318,,,,,,,1,Vyndaqel,,,,,,,,,,TRUE,,,,,Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis.,Pfizer Inc.,Cardiomyopathy of Transthyretin-Mediated Amyloidosis,3-May-19,5/3/19,tafamidis meglumine,No,441,264,177,0,NCT01994889,,,,,,,1,Skyrizi,,,,,,,,TRUE,,,,,,,Skyrizi (risankizumab-rzaa) is an interleukin-23 (IL-23) inhibitor for the treatment of plaque psoriasis.,AbbVie Inc.,Plaque Psoriasis,23-Apr-19,4/23/19,risankizumab-rzaa,No,1305,1005,300,0,NCT02684370,NCT02684357,NCT02672852,NCT02694523,,,,1,Balversa,,,,,,,,TRUE,,,,,,,"Balversa (erdafitinib) is a once-daily, oral, pan-fibroblast growth factor receptor for the treatment of patients with locally advanced or metastatic urothelial cancer.","Janssen Pharmaceuticals, Inc.",Urothelial Carcinoma,12-Apr-19,4/12/19,erdafitinib,No,87,87,0,0,NCT02365597,,,,,,,1,Evenity,,,,,,,,,TRUE,,,,,,Evenity (romosozumab) is an anti-sclerostin monoclonal antibody for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.,Amgen Inc.,Osteoporosis,9-Apr-19,4/9/19,romosozumab,No,11273,5635,3591,2047,NCT01575834,NCT01631214,,,,,,1,Mayzent,,,,,,,,TRUE,,,,,,,"Mayzent (siponimod) is a sphingosine-1-phosphate receptor modulator for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.",Novartis,Multiple Sclerosis,26-Mar-19,3/26/19,siponimod,No,1645,1099,546,0,NCT01665144,,,,,,,1,Sunosi,,,,,,,,,,TRUE,,,,,Sunosi (solriamfetol) is a selective dopamine and norepinephrine reuptake inhibitor (DNRI) for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea (OSA).,Jazz Pharmaceuticals plc,"Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome",20-Mar-19,3/20/19,solriamfetol,No,918,543,375,0,NCT02348593,NCT02348606,NCT02348619,NCT02348632,,,,1,Zulresso,,,,,,,,,,TRUE,,,,,Zulresso (brexanolone) is a gamma-aminobutyric acid A (GABAA) receptor positive allosteric modulator indicated for the treatment of postpartum depression (PPD).,Sage Therapeutics,Postpartum Depression,19-Mar-19,3/19/19,brexanolone,No,226,130,96,0,NCT02942004,NCT02942017,,,,,,1,Rocklatan,,,,,,,,,,,,,TRUE,,"Rocklatan (netarsudil and latanoprost ophthalmic solution) is a fixed dose combination of the Rho kinase inhibitor netarsudil (Rhopressa) and the prostaglandin F2‘± analogue latanoprost (Xalatan), indicated to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.","Aerie Pharmaceuticals, Inc.","Glaucoma (Open Angle), Intraocular Hypertension",12-Mar-19,3/12/19,netarsudil and latanoprost ophthalmic solution,No,1468,499,0,969,NCT02558400,NCT02674854,,,,,,1,Egaten,,,,,,,,,,,TRUE,,,,"Egaten (triclabendazole) is a benzimidazole anthelmintic indicated for the treatment of fascioliasis,  a neglected tropical disease (NTD) caused by liver flukes Fasciola hepatica and Fasciola gigantica.",Novartis,Fascioliasis,13-Feb-19,2/13/19,triclabendazole,No,466,466,0,0,The FDA approved EGATEN based primarily on evidence from 9 clinical trials of 466 patients with fascioliasisƒ.these were old trials and not conducted under FDA authority.,,,,,,,1,Cablivi,,TRUE,,,,,,,,,,,,,"Cablivi (caplacizumab-yhdp) is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.",Ablynx NV,Acquired Thrombotic Thrombocytopenic Purpura,6-Feb-19,2/6/19,caplacizumab-yhdp,No,145,72,73,0,NCT02553317,NCT01151423,,,,,,1,Jeuveau,,,,TRUE,,,,,,,,,,,Jeuveau (prabotulinumtoxinA) is a proprietary 900 kDa purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar (frown) lines.,"Evolus, Inc.",Glabellar Lines,1-Feb-19,2/1/19,prabotulinumtoxinA,No,654,492,162,0,NCT02334423,NCT02334436,,,,,,1,Ultomiris,,,,,,,,TRUE,,,,,,,Ultomiris (ravulizumab-cwvz) is a long-acting C5 complement inhibitor for:,"Alexion Pharmaceuticals, Inc.","Paroxysmal Nocturnal Hemoglobinuria, Hemolytic Uremic Syndrome",21-Dec-18,12/21/18,ravulizumab-cwvz,No,441,222,0,219,NCT02946463,NCT03056040,,,,,,1,Elzonris,,,,,,,,TRUE,,,,,,,Elzonris (tagraxofusp-erzs) is a CD123-directed cytotoxin for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN).,"Stemline Therapeutics, Inc.",Blastic Plasmacytoid Dendritic Cell Neoplasm,21-Dec-18,12/21/18,tagraxofusp-erzs,No,28,28,0,0,NCT02113982,NCT02113982,,,,,,1,Asparlas,,,,,,,,TRUE,,,,,,,Asparlas (calaspargase pegol-mknl) is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapy regimen for the treatment of acute lymphoblastic leukemia.,Servier Pharmaceuticals LLC,Acute Lymphoblastic Leukemia,20-Dec-18,12/20/18,calaspargase pegol-mknl,No,124,124,0,0,NCT01574274,NCT00671034,,,,,,1,Motegrity,TRUE,,,,,,,,,,,,,,Motegrity (prucalopride) is a selective serotonin type 4 receptor agonist for the treatment of chronic idiopathic constipation (CIC) in adults.,Shire plc,Chronic Idiopathic Constipation,14-Dec-18,12/14/18,prucalopride,No,2484,1237,1247,0,NCT01116206,NCT01147926,NCT00488137,NCT00483886,NCT00485940,NCT01424228,,1,Xospata,,,,,,,,TRUE,,,,,,,Xospata (gilteritinib) is a FLT3/AXL kinase inhibitor indicated for the treatment of patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.,Astellas Pharma Inc.,Acute Myeloid Leukemia,28-Nov-18,11/28/18,gilteritinib,No,138,138,0,0,NCT02421939,,,,,,,1,Firdapse,,,,,,,,,,TRUE,,,,,"Firdapse (amifampridine phosphate) is a nonspecific, voltage-dependent, potassium (K+) channel blocker for the treatment of Lambert Eaton myasthenic syndrome (LEMS) in adults.","Catalyst Pharmaceuticals, Inc.",Lambert Eaton Myasthenic Syndrome,28-Nov-18,11/28/18,amifampridine phosphate,No,64,29,35,0,NCT01377922,NCT02970162,,,,,,1,Vitrakvi,,,,,,,,TRUE,,,,,,,Vitrakvi (larotrectinib) is an oral selective tropomyosin receptor kinase (TRK) inhibitor for the treatment solid tumors harboring NTRK-fusion proteins.,"Loxo Oncology, Inc.",TRK Fusion Cancers,26-Nov-18,11/26/18,larotrectinib,No,55,55,0,0,NCT02122913,NCT02637687,NCT02576431,,,,,1,Daurismo,,,,,,,,TRUE,,,,,,,Daurismo (glasdegib) is a hedgehog pathway inhibitor indicated for the combination treatment of adult patients äŠ«75 years with newly-diagnosed acute myeloid leukemia (AML).,Pfizer Inc.,Acute Myeloid Leukemia,21-Nov-18,11/21/18,glasdegib,No,115,77,0,38,NCT01546038,,,,,,,1,Gamifant,,,,,,,,TRUE,,,,,,,Gamifant (emapalumab-lzsg) is an interferon gamma (IFN‘_) blocking antibody for the treatment of patients with primary hemophagocytic lymphohistiocytosis (HLH).,Novimmune SA,Hemophagocytic Lymphohistiocytosis,20-Nov-18,11/20/18,emapalumab-lzsg,No,27,27,0,0,NCT01818492,NCT02069899,,,,,,2,Aemcolo,,,,,,,TRUE,,,,,,TRUE,,"Aemcolo (rifamycin) is a broad spectrum, orally non-absorbable antibiotic for the treatment of traveleräó»s diarrhea caused by noninvasive strains of Escherichia coli.","Cosmo Technologies, Ltd.",Traveler's Diarrhea,16-Nov-18,11/16/18,rifamycin,No,264,199,65,0,NCT01142089,NCT01208922,,,,,,1,Yupelri,,,,,,,,,,,,TRUE,,,Yupelri (revefenacin) is a long-acting muscarinic antagonist (LAMA) for the treatment of chronic obstructive pulmonary disease (COPD).,"Theravance Biopharma, Inc.",Chronic Obstructive Pulmonary Disease,9-Nov-18,11/9/18,revefenacin,No,812,395,417,0,NCT02459080,NCT02512510,,,,,,1,Lorbrena,,,,,,,,TRUE,,,,,,,Lorbrena (lorlatinib) is an anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for the treatment of patients with ALK-positive metastatic non-small cell lung cancer (NSCLC).,Pfizer Inc.,Non-Small Cell Lung Cancer,2-Nov-18,11/2/18,lorlatinib,No,215,215,0,0,NCT01970865,,,,,,,1,Xofluza,,,,,,,TRUE,,,,,,,,"Xofluza (baloxavir marboxil) is a polymerase acidic (PA) endonuclease inhibitor for the treatment of influenza (the flu) in people 12 years of age and older who have had flu symptoms for no more than 48 hours and who are otherwise healthy, or at high risk of developing flu-related complications.","Genentech, Inc.",Influenza,24-Oct-18,10/24/18,baloxavir marboxil,No,885,555,330,0,Studyæ1518T0821,NCT02954354,,,,,,1,Talzenna,,,,,,,,TRUE,,,,,,,Talzenna (talazoparib) is an oral poly ADP ribose polymerase (PARP) inhibitor indicated for the treatment of patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) HER2-negative locally advanced or metastatic breast cancer.,Pfizer Inc.,Breast Cancer,16-Oct-18,10/16/18,talazoparib,No,431,287,0,144,NCT01945775,,,,,,,1,Tegsedi,,,,,,,,,,TRUE,,,,,Tegsedi (inotersen) is an antisense oligonucleotide inhibitor of the transthyretin (TTR) protein for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. ,"Ionis Pharmaceuticals, Inc.",Amyloidogenic Transthyretin Amyloidosis,5-Oct-18,10/5/18,inotersen,No,173,113,60,0,NCT 01737398,,,,,,,1,Revcovi,,,,,,,,TRUE,,,,,,,Revcovi (elapegademase-lvlr) is a recombinant adenosine deaminase indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID).,"Leadiant Biosciences, Inc.",Adenosine Deaminase Severe Combined Immune,5-Oct-18,10/5/18,elapegademase-lvlr,No,10,10,0,0,NCT01420627,STM-279-301,,,,,,1,Nuzyra,,,,,,,TRUE,,,,,,,,Nuzyra (omadacycline) is an aminomethylcycline tetracycline antibiotic for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).,"Paratek Pharmaceuticals, Inc.","Skin and Structure Infection, Pneumonia",2-Oct-18,10/2/18,omadacycline,No,2164,1083,0,1081,NCT02531438,NCT02378480,NCT02877927,,,,,1,Seysara,,,,,,,TRUE,,,,,,,,"Seysara (sarecycline) is an oral, narrow spectrum tetracycline-derived antibiotic for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.","Almirall, S.A.",Acne,1-Oct-18,10/1/18,sarecycline,No,2002,1002,1000,0,NCT02320149,NCT02322866,,,,,,1,Libtayo,,,,,,,,TRUE,,,,,,,Libtayo (cemiplimab-rwlc) is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC).,Sanofi,Squamous Cell Carcinoma,28-Sep-18,9/28/18,cemiplimab-rwlc,No,108,108,0,0,NCT02383212,NCT02760498,,,,,,1,Emgality,,,,,,,,,,TRUE,,,,,"Emgality (galcanezumab-gnlm) is a calcitonin gene-related peptide (CGRP) antagonist indicated for the preventive treatment of migraine, and for the treatment of episodic cluster headache.",Eli Lilly and Company,"Migraine Prophylaxis, Cluster Headache",27-Sep-18,9/27/18,galcanezumab-gnlm,No,2831,1418,1413,0,NCT02614183,NCT02614196,NCT02614261,,,,,1,Vizimpro,,,,,,,,TRUE,,,,,,,"Vizimpro (dacomitinib) is an oral, once-daily, irreversible pan-human epidermal growth factor receptor tyrosine kinase inhibitor (TKI) indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as detected by an FDA-approved test.",Pfizer Inc.,Non-Small Cell Lung Cancer,27-Sep-18,9/27/18,dacomitinib,No,452,227,0,225,NCT01774721,,,,,,,1,Copiktra,,,,,,,,TRUE,,,,,,,"Copiktra (duvelisib) is a first-in-class, oral, dual phosphoinositide-3-kinase (PI3K)-delta/PI3K-gamma inhibitor for the treatment relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and relapsed or refractory follicular lymphoma (FL).","Verastem, Inc.","Chronic Lymphocytic Leukemia, Follicular Lymphoma",24-Sep-18,9/24/18,duvelisib,No,279,178,0,101,NCT02004522,NCT02204982,,,,,,1,Ajovy,,,,,,,,,,TRUE,,,,,Ajovy (fremanezumab) is a fully-humanized monoclonal antibody targeting the calcitonin gene-related peptide (CGRP) ligand indicated for the preventive treatment of migraine.,Teva Pharmaceutical Industries Ltd.,Migraine Prophylaxis,14-Sep-18,9/14/18,fremanezumab,No,1986,1325,661,0,NCT02629861,NCT02621931,,,,,,1,Lumoxiti,,,,,,,,TRUE,,,,,,,Lumoxiti (moxetumomab pasudotox-tdfk) is an anti-CD22 recombinant immunotoxin for the treatment of adult patients with hairy cell leukemia.,AstraZeneca and MedImmune,Hairy Cell Leukemia,13-Sep-18,9/13/18,moxetumomab pasudotox-tdfk,No,80,80,0,0,NCT01829711,,,,,,,1,Pifeltro,,,,,,,TRUE,,,,,,,,Pifeltro (doravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of HIV-1 infection.,Merck,HIV Infection,30-Aug-18,8/30/18,doravirine,No,1494,747,0,747,NCT02275780,NCT02403674,,,,,,1,Xerava,,,,,,,TRUE,,,,,,,,Xerava (eravacycline) is a fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections.,"Tetraphase Pharmaceuticals, Inc.",Complicated Intra-Abdominal Infections,27-Aug-18,8/27/18,eravacycline,No,846,415,0,431,NCT01844856,NCT02784704,,,,,,1,Takhzyro,,TRUE,,,,,,,,,,,,,Takhzyro (lanadelumab-flyo) is a plasma kallikrein inhibitor (monoclonal antibody) for the prevention of angioedema attacks in patients with hereditary angioedema.,Shire plc,Hereditary Angioedema,23-Aug-18,8/23/18,lanadelumab-flyo,No,125,84,41,0,NCT02586805,NCT02741596,,,,,,1,Oxervate,,,,,,,,,,,,,TRUE,,Oxervate (cenegermin) is a recombinant human nerve growth factor (rhNGF) ophthalmic solution indicated for the treatment of neurotrophic keratitis.,Dompí© farmaceutici SpA,Neurotrophic Keratitis,22-Aug-18,8/22/18,cenegermin,No,148,73,75,0,NCT01756456,NCT02227147,,,,,,1,Diacomit,,,,,,,,,,TRUE,,,,,Diacomit (stiripentol) is an anticonvulsant indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam.,Biocodex,Dravet Syndrome,20-Aug-18,8/20/18,stiripentol,No,64,33,31,0,Data were not collected per local regulatory authority.,,,,,,,1,Onpattro,,,,,,,,,,TRUE,,,,,Onpattro (patisiran) is a small interfering ribonucleic acid (siRNA) therapeutic  for the treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR).,"Alnylam Pharmaceuticals, Inc.",Hereditary Transthyretin-Mediated Amyloidosis (hATTR),10-Aug-18,8/10/18,patisiran,No,225,148,77,0,NCT01960348,,,,,,,1,Galafold,TRUE,,,,,,,,,,,,,,Galafold (migalastat) is an alpha-galactosidase A (alpha-Gal A) pharmacological chaperone indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant.,Amicus Therapeutics,Fabry Disease,10-Aug-18,8/10/18,migalastat,No,45,25,20,0,NCT00925301,,,,,,,1,Annovera,,,,,TRUE,,,,,,,,,,Annovera (ethinyl estradiol and segesterone acetate) is an estrogen and progestin vaginal contraceptive system indicated to prevent pregnancy for up to a year.,The Population Council,Contraception,10-Aug-18,8/10/18,ethinyl estradiol and segesterone acetate,No,2308,2308,0,0,NCT0455156,NCT00263342,,,,,,1,Poteligeo,,,,,,,,TRUE,,,,,,,"Poteligeo (mogamulizumab-kpkc) is a humanized monoclonal antibody (mAb) directed against CC chemokine receptor 4 (CCR4) for the treatment of Mycosis Fungoides (MF) and Sí©zary Syndrome (SS), the most common subtypes of cutaneous T-cell lymphoma (CTCL).","Kyowa Hakko Kirin Co., Ltd.",Mycosis Fungoides; Sí©zary Syndrome,8-Aug-18,8/8/18,mogamulizumab-kpkc,No,372,186,0,186,NCT01728805,,,,,,,1,Mulpleta,,TRUE,,,,,,,,,,,,,"Mulpleta (lusutrombopag) is a once-daily, orally administered, thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in patients with chronic liver disease who are scheduled to undergo a medical or dental procedure.",Shionogi Inc.,Thrombocytopenia,31-Jul-18,7/31/18,lusutrombopag,No,312,157,155,0,NCT02389621,L_PLUS 1,,,,,,1,Orilissa,,,,,,TRUE,,,,,,,,,Orilissa (elagolix) is an orally administered gonadotropin-releasing hormone (GnRH) antagonist for the management of moderate to severe pain associated with endometriosis.,"AbbVie, Inc.",Endometriosis,23-Jul-18,7/23/18,elagolix,No,1664,938,726,0,NCT01620528,NCT01931670,,,,,,1,Tibsovo,,,,,,,,TRUE,,,,,,,Tibsovo (ivosidenib) is an isocitrate dehydrogenase-1 (IDH1) inhibitor for the treatment of patients with acute myeloid leukemia who have an IDH1 mutation.,"Agios Pharmaceuticals, Inc.",Acute Myeloid Leukemia,20-Jul-18,7/20/18,ivosidenib,No,174,174,0,0,NCT02074839,,,,,,,1,Krintafel,,,,,,,,,,,TRUE,,,,Krintafel (tafenoquine) is an 8-aminoquinoline derivative antimalarial for the radical cure (prevention of relapse) of Plasmodium vivax malaria.,GlaxoSmithKline,Malaria,20-Jul-18,7/20/18,tafenoquine,No,371,317,54,0,NCT01376167,NCT01376167,,,,,,1,TPOXX,,,,,,,TRUE,,,,,,,,TPOXX (tecovirimat) is an orthopoxvirus-specific antiviral indicated for the treatment of human smallpox disease.,"SIGA Technologies, Inc.",Smallpox,13-Jul-18,7/13/18,tecovirimat,No,0,0,0,0,"The effectiveness of TPOXX for treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible, and inducing smallpox disease in humans to study the drugÍs efficacy is not ethical.",,,,,,,1,Braftovi,,,,,,,,TRUE,,,,,,,"Braftovi (encorafenib) is a kinase inhibitor indicated, in combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.",Array BioPharma Inc.,Melanoma -- Metastatic,27-Jun-18,6/27/18,encorafenib,No,577,386,0,191,NCT01909453,,,,,,,1,Mektovi,,,,,,,,TRUE,,,,,,,"Mektovi (binimetinib)  is a kinase inhibitor indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.",Array BioPharma Inc.,Melanoma -- Metastatic,27-Jun-18,6/27/18,binimetinib,No,383,192,0,191,NCT01909453,,,,,,,1,Zemdri,,,,,,,TRUE,,,,,,,,Zemdri (plazomicin) is an aminoglycoside antibacterial for the treatment of complicated urinary tract infections.,"Achaogen, Inc.",Urinary Tract Infection,25-Jun-18,6/25/18,plazomicin,No,406,198,0,208,NCT02486627,,,,,,,1,Epidiolex,,,,,,,,,,TRUE,,,,,"Epidiolex (cannabidiol) is a prescription pharmaceutical formulation of highly-purified, marijuana plant-derived cannabidiol (CBD) for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients two years of age or older.",GW Pharmaceuticals plc,"Lennox-Gastaut Syndrome, Dravet Syndrome",25-Jun-18,6/25/18,cannabidiol,No,396,235,161,0,NCT02224560,NCT02224690,,,,,,1,moxidectin,,,,,,,,,,,TRUE,,,,Moxidectin is a macrocyclic lactone anthelmintic medicine indicated for the treatment of river blindness (onchocerciasis) in patients aged 12 years and older.,Medicines Development for Global Health,Onchocerciasis,13-Jun-18,6/13/18,onchocerciasis,No,1472,977,0,495,NCT00790998,NCT00300768,,,,,,1,Olumiant,,,,,,,,TRUE,,,,,,,Olumiant (baricitinib) is a Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.,Eli Lilly and Company and Incyte Corporation ,Rheumatoid Arthritis,31-May-18,5/31/18,baricitinib,No,807,403,404,0,NCT01721057,NCT01721044,,,,,,1,Palynziq,,,,,,,,,,TRUE,,,,,Palynziq (pegvaliase-pqpz) is a phenylalanine-metabolizing enzyme indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria.,BioMarin Pharmaceutical Inc.,Phenylketonuria,24-May-18,5/24/18,pegvaliase-pqpz,No,86,58,28,0,NCT01819727,,,,,,,1,Doptelet,,TRUE,,,,,,,,,,,,,"Doptelet (avatrombopag) is a second generation, orally administered thrombopoietin receptor agonist (TPO-RA) indicated for the treatment of:","Dova Pharmaceuticals, Inc.","Thrombocytopenia, Idiopathic (Immune) Thrombocytopenic Purpura",21-May-18,5/21/18,avatrombopag,No,435,277,158,0,NCT01972529,NCT01976104,,,,,,1,Lokelma,,,,,,,,,,,,,,TRUE,Lokelma (sodium zirconium cyclosilicate) is a potassium binder indicated for the treatment of hyperkalemia in adults.,AstraZeneca,Hyperkalemia,18-May-18,5/18/18,sodium zirconium cyclosilicate,No,1828,1588,240,0,NCT01737697,NCT02088073,NCT02163499,,,,,1,Aimovig,,,,,,,,,,TRUE,,,,,"Aimovig (erenumab-aooe) is a calcitonin gene-related peptide (CGRP) receptor antagonist indicated for the preventive treatment of migraine.",Amgen Inc.,Migraine Prophylaxis,17-May-18,5/17/18,erenumab-aooe,No,2199,1303,896,0,NCT02456740,NCT02483585,NCT02066415,,,,,1,Lucemyra,,,,,,,,,,TRUE,,,,,Lucemyra (lofexidine hydrochloride) is a selective alpha 2-adrenergic receptor agonist indicated for reducing the severity of withdrawal symptoms in patients experiencing opioid withdrawal.,US WorldMeds,Opiate Withdrawal,16-May-18,5/16/18,lofexidine hydrochloride,No,866,585,281,0,NCT01863186,NCT00235729,,,,,,1,Tavalisse,,TRUE,,,,,,,,,,,,,"Tavalisse (fostamatinib) is an oral spleen tyrosine kinase (SYK) inhibitor for the treatment of patients with chronic immune thrombocytopenia (ITP).","Rigel Pharmaceuticals, Inc.",Idiopathic (Immune) Thrombocytopenic Purpura,17-Apr-18,4/17/18,fostamatinib,No,150,101,49,0,NCT02076399,NCT02076412,,,,,,1,Crysvita,,,,,,,,,TRUE,,,,,,Crysvita (burosumab-twza) is a fibroblast growth factor 23 (FGF23) blocking antibody for the treatment of x-linked hypophosphatemia (XLH).,Ultragenyx Pharmaceutical Inc.,X-Linked Hypophosphatemia,17-Apr-18,4/17/18,burosumab-twza,No,187,121,66,0,NCT02163577,NCT02750618,NCT02526160,NCT02537431,,,,1,Ilumya,,,,,,,,TRUE,,,,,,,"Ilumya (tildrakizumab-asmn) is a humanized, anti-IL-23p19 monoclonal antibody for the treatment of moderate-to-severe plaque psoriasis.",Sun Pharmaceutical Industries Ltd.,Plaque Psoriasis,20-Mar-18,3/20/18,tildrakizumab-asmn,No,926,616,310,0,NCT01722331,NCT01729754,,,,,,1,Trogarzo,,,,,,,TRUE,,,,,,,,Trogarzo (ibalizumab-uiyk) is a CD4-directed post-attachment HIV-1 inhibitor for the treatment of multidrug resistant human immunodeficiency virus-1 (HIV-1) infection in heavily treatment-experienced adults.,TaiMed Biologics USA Corp.,HIV Infection,6-Mar-18,3/6/18,ibalizumab-uiyk,No,40,40,0,0,NCT02475629,,,,,,,1,Erleada,,,,,,,,TRUE,,,,,,,"Erleada (apalutamide) is an oral androgen receptor inhibitor for the treatment of metastatic castration-sensitive prostate cancer, and non-metastatic castration-resistant prostate cancer.","Janssen Pharmaceuticals, Inc.",Prostate Cancer,14-Feb-18,2/14/18,apalutamide,No,1207,806,401,0,NCT01946204,,,,,,,1,Symdeko,,,,,,,,,,,,TRUE,,,Symdeko (ivacaftor/tezacaftor tablets and ivacaftor tablets) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator and CFTR corrector combination for the treatment of cystic fibrosis in patients aged 6 years and older who are homozygous for the F508del mutation or who have at least one mutation in the CFTR) gene that is responsive to Symdeko.,Vertex Pharmaceuticals Incorporated,Cystic Fibrosis,12-Feb-18,2/12/18,ivacaftor/tezacaftor tablets and ivacaftor tablets,No,1150,492,502,156,NCT02347657,NCT02392234,NCT02516410,,,,,1,Biktarvy,,,,,,,TRUE,,,,,,,,"Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) is an integrase strand transfer inhibitor and emtricitabine/tenofovir alafenamide (Descovy) combination for the treatment of HIV-1 infection in adults.","Gilead Sciences, Inc.",HIV Infection,7-Feb-18,2/7/18,"bictegravir, emtricitabine and tenofovir alafenamide",No,2414,1206,0,1208,NCT02607930,NCT02607956,NCT02603120,NCT02603107,,,,1,Lutathera,,,,,,,,,,,,,,TRUE,Lutathera (lutetium Lu 177 dotatate) is a Lu-177-labeled somatostatin analogue indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors. ,Advanced Accelerator Applications S.A.,Gastroenteropancreatic Neuroendocrine Tumors,26-Jan-18,1/26/18,lutetium Lu 177 dotatate,No,589,476,0,113,NCT01578239,ERASMUS study,,,,,,1,Giapreza,,,TRUE,,,,,,,,,,,,Giapreza (angiotensin II) is a synthetic human angiotensin II vasoconstrictor indicated for the treatment of hypotension in adults with septic or other distributive shock.,La Jolla Pharmaceutical Company,"Hypotension, Shock",21-Dec-17,12/21/17,angiotensin II,No,321,163,158,0,NCT02338843,,,,,,,1,Macrilen,,,,,,,,,,,,,,TRUE,Macrilen (macimorelin) is a growth hormone (GH) secretagogue receptor agonist indicated for the diagnosis of adult growth hormone deficiency.,Aeterna Zentaris Inc.,Diagnosis of Adult Growth Hormone Deficiency,20-Dec-17,12/20/17,macimorelin,No,140,59,81,0,NCT02558829,,,,,,,1,Steglatro,TRUE,,,,,,,,,,,,,,Steglatro (ertugliflozin) is a sodium-glucose co-transporter-2 (SGLT2) inhibitor used to help improve glycemic control in adults with type 2 diabetes.,Merck,Diabetes Type 2,19-Dec-17,12/19/17,ertugliflozin,No,4847,3400,763,684,NCT01958671,NCT02033889,NCT02036515,NCT01986855,NCT01999218,NCT02099110,NCT02226003,1,Rhopressa,,,,,,,,,,,,,TRUE,,"Rhopressa (netarsudil ophthalmic solution) is a Rho kinase inhibitor for the treatment of open-angle glaucoma or ocular hypertension.","Aerie Pharmaceuticals, Inc.",Glaucoma,18-Dec-17,12/18/17,netarsudil ophthalmic solution,No,881,428,0,453,NCT02207491,NCT02207621,NCT02558374,,,,,1,Xepi,,,,TRUE,,,,,,,,,,,Xepi (ozenoxacin) is a topical non-fluorinated quinolone for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes.,"Medimetriks Pharmaceuticals, Inc.",Impetigo,11-Dec-17,12/11/17,ozenoxacin,No,723,361,362,0,NCT01397461,NCT02090764,,,,,,1,Ozempic,TRUE,,,,,,,,,,,,,,Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the treatment of adults with type 2 diabetes.,Novo Nordisk,Diabetes Type 2,5-Dec-17,12/5/17,semaglutide,No,7196,4113,1911,1172,NCT02054897,NCT01930188,NCT01885208,NCT02128932,NCT02305381,NCT01720446,,1,Hemlibra,,TRUE,,,,,,,,,,,,,Hemlibra (emicizumab-kxwh) is a bispecific factor IXa- and factor X-directed antibody indicated to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors.,"Genentech, Inc.","Hemophilia A with Inhibitors, Hemophilia A",16-Nov-17,11/16/17,emicizumab-kxwh,No,176,120,0,56,NCT02622321,NCT02795767,,,,,,1,Mepsevii,TRUE,,,,,,,,,,,,,,"Mepsevii (vestronidase alfa) is a recombinant human lysosomal beta glucuronidase indicated for the treatment of Mucopolysaccharidosis VII (MPS VII, Sly syndrome).","Ultragenyx Pharmaceutical, Inc.",Mucopolysaccharidosis Type VII,15-Nov-17,11/15/17,vestronidase alfa,No,27,15,12,,NCT02230566,NCT02432144,NCT01856218,,,,,1,Fasenra,,,,,,,,,,,,TRUE,,,Fasenra (benralizumab) is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody indicated for the treatment of patients with severe eosinophilic asthma.,AstraZeneca,Asthma,14-Nov-17,11/14/17,benralizumab,No,1805,1045,760,,NCT01238861,NCT01928771,NCT01914757,NCT02075255,NCT02322775,,,1,Prevymis,,,,,,,TRUE,,,,,,,,Prevymis (letermovir) is a CMV DNA terminase complex inhibitor indicated for the prophylaxis of cytomegalovirus (CMV) infection and disease in adult allogeneic hematopoietic stem cell transplant patients.,"Merck & Co., Inc.",CMV Prophylaxis,8-Nov-17,11/8/17,letermovir,No,495,325,170,0,NCT02137772,,,,,,,1,Vyzulta,,,,,,,,,,,,,TRUE,,Vyzulta (latanoprostene bunod) is a nitric oxide donating prostaglandin receptor agonist for the treatment of patients with open angle glaucoma or ocular hypertension.,"Valeant Pharmaceuticals International, Inc.","Glaucoma (Open Angle), Intraocular Hypertension",2-Nov-17,11/2/17,latanoprostene bunod,No,840,569,0,271,NCT01749904,NCT01749930,,,,,,1,Calquence,,,,,,,,TRUE,,,,,,,"Calquence (acalabrutinib) is a highly selective, potent, Bruton tyrosine kinase (BTK) inhibitor for the treatment of mantle cell lymphoma (MCL), and chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma.",AstraZeneca,Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia,31-Oct-17,10/31/17,acalabrutinib,No,124,124,0,0,NCT02213926,,,,,,,1,Verzenio,,,,,,,,TRUE,,,,,,,"Verzenio (abemaciclib) is a selective ATP-competitive inhibitor of cyclin dependent kinases (CDK) 4 and 6 indicated for the treatment of patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.",Eli Lilly and Company,Breast Cancer,28-Sep-17,9/28/17,abemaciclib,No,801,578,223,0,NCT02107703,NCT02102490,,,,,,1,Solosec,,,,,,,,,,,TRUE,,,,Solosec (secnidazole) is a nitroimidazole antimicrobial for use as a single-dose oral therapy in the treatment of bacterial vaginosis (BV).,"Symbiomix Therapeutics, LLC",Bacterial Vaginosis,15-Sep-17,9/15/17,secnidazole,No,288,169,119,0,NCT03937869,NCT03935217,,,,,,1,Aliqopa,,,,,,,,TRUE,,,,,,,Aliqopa (copanlisib) is a phosphatidylinositol-3-kinase (PI3K) inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL).,"Bayer Healthcare Pharmaceuticals, Inc.",Follicular Lymphoma,14-Sep-17,9/14/17,copanlisib,No,104,104,0,0,NCT01660451,,,,,,,1,Vabomere,,,,,,,TRUE,,,,,,,,Vabomere (meropenem and vaborbactam) is a carbapenem and beta-lactamase inhibitor combination for the treatment of complicated urinary tract infections (cUTIs).,"Chemo Research, S. L.",Chagas Disease,29-Aug-17,8/29/17,meropenem and vaborbactam,No,545,272,0,273,NCT02166476,,,,,,,1,Besponsa,,,,,,,,TRUE,,,,,,,"Besponsa (inotuzumab ozogamicin) is a CD22 monoclonal antibody and calicheamicin cytotoxic agent conjugate for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).",Pfizer Inc.,Acute Lymphoblastic Leukemia,17-Aug-17,8/17/17,inotuzumab ozogamicin,No,326,164,0,162,NCT01564784,,,,,,,1,Mavyret,,,,,,,TRUE,,,,,,,,"Mavyret (glecaprevir/pibrentasvir) is a fixed-dose combination of glecaprevir, an NS3/4A protease inhibitor, and pibrentasvir, an NS5A inhibitor, indicated for the treatment of all major genotypes (GT1-6) of chronic hepatitis C.",AbbVie Inc.,Chronic Hepatitis C,3-Aug-17,8/3/17,glecaprevir/pibrentasvir,No,2589,2473,0,116,NCT02604017,NCT02243293,NCT02640157,NCT02636595,NCT02243280,NCT02642432,NCT02651194,NCT024467171,Idhifa,,,,,,,,TRUE,,,,,,,"Idhifa (enasidenib) is a first-in-class, oral, targeted inhibitor of mutant isocitrate dehydrogenase 2 (IDH2) for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation.",Celgene Corporation,Acute Myeloid Leukemia,1-Aug-17,8/1/17,enasidenib,No,199,199,0,0,NCT01915498,,,,,,,1,Vosevi,,,,,,,TRUE,,,,,,,,"Vosevi (sofosbuvir, velpatasvir and voxilaprevir or SOF/VEL/VOX) is a fixed-dose combination of a nucleotide analog NS5B polymerase inhibitor (SOF), a pangenotypic NS5A inhibitor (VEL), and a pangenotypic NS3/4A protease inhibitor (VOX) for the treatment of genotype 1-6 chronic hepatitis C virus (HCV) infection.","Gilead Sciences, Inc.",Chronic Hepatitis C,18-Jul-17,7/18/17,"sofosbuvir, velpatasvir and voxilaprevir or SOF/VEL/VOX",No,749,597,152,0,NCT02607735,NCT02639247,,,,,,1,Nerlynx,,,,,,,,TRUE,,,,,,,Nerlynx (neratinib) is a tyrosine kinase inhibitor for the extended adjuvant treatment of early-stage HER2-positive breast cancer.,"Puma Biotechnology, Inc.",Breast Cancer -- Adjuvant,17-Jul-17,7/17/17,neratinib,No,2840,1420,1420,0,NCT00878709,,,,,,,1,Tremfya,,,,,,,,TRUE,,,,,,,Tremfya (guselkumab) is an interleukin-23 blocker indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.,"Janssen Biotech, Inc.",Plaque Psoriasis,13-Jul-17,7/13/17,guselkumab,No,1829,825,422,582,NCT02207231,NCT02207244,NCT02203032,,,,,1,Bevyxxa,,TRUE,,,,,,,,,,,,,"Bevyxxa (betrixaban) is an oral, once-daily Factor Xa inhibitor anticoagulant for the extended-duration prophylaxis of venous thromboembolism (VTE) in at-risk adult patients hospitalized for an acute medical illness.",Portola Pharmaceuticals Inc.,Prevention of Venous Thromboembolism,23-Jun-17,6/23/17,betrixaban,No,7441,3721,3720,0,NCT01583218,,,,,,,1,Baxdela,,,,,,,TRUE,,,,,,,,Baxdela (delafloxacin) is a fluoroquinolone antibacterial indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.,Melinta Therapeutics,"Skin and Structure Infection, Pneumonia",19-Jun-17,6/19/17,delafloxacin,No,1510,754,0,756,NCT01811732,NCT02679573,,,,,,1,Kevzara,,,,,,,,TRUE,,,,,,,Kevzara (sarilumab) is an interleukin-6 receptor (IL-6R) antibody for the treatment of adults with rheumatoid arthritis.,"Sanofi and Regeneron Pharmaceuticals, Inc.",Rheumatoid Arthritis,22-May-17,5/22/17,sarilumab,No,1743,1164,579,0,NCT01061736,NCT01709578,,,,,,1,Radicava,,,,,,,,,,TRUE,,,,,"Radicava (edaravone) is a free radical scavenger that relieves the effects of oxidative stress, a likely factor in the onset and progression of amyotrophic lateral sclerosis.",Mitsubishi Tanabe Pharma,Amyotrophic Lateral Sclerosis,5-May-17,5/5/17,edaravone,No,137,69,68,0,NCT01492686,,,,,,,1,Imfinzi,,,,,,,,TRUE,,,,,,,Imfinzi (durvalumab) is an anti-PD-L1 (programmed death ligand-1) human monoclonal antibody for the treatment of patients with metastatic urothelial carcinoma and for the treatment of patients with unresectable non-small cell lung cancer that has not progressed after chemoradiation.,AstraZeneca,"Urothelial Carcinoma, Non-Small Cell Lung Cancer",1-May-17,5/1/17,durvalumab,No,182,182,0,0,NCT01693562,,,,,,,1,Rydapt,,,,,,,,TRUE,,,,,,,"Rydapt (midostaurin) is an oral, multi-targeted kinase inhibitor for the treatment of acute myeloid leukemia (AML) in newly-diagnosed adults with an FMS-like tyrosine kinase-3 (FLT3) mutation, and for the treatment of advanced systemic mastocytosis (SM), which includes aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN) and mast cell leukemia.",Novartis,"Acute Myeloid Leukemia, Mastocytosis",28-Apr-17,4/28/17,midostaurin,No,833,476,357,0,NCT00651261,NCT00782067,,,,,,1,Tymlos,,,,,,TRUE,,,,,,,,,Tymlos (abaloparatide) is a synthetic peptide analog of hPTHrP (human parathyroid hormone-related protein) for the treatment of postmenopausal women with osteoporosis. ,"Radius Health, Inc.",Osteoporosis,28-Apr-17,4/28/17,abaloparatide,No,1645,824,821,0,NCT01343004,NCT01657162,,,,,,1,Alunbrig,,,,,,,,TRUE,,,,,,,"Alunbrig (brigatinib) is an anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with anaplastic lymphoma kinase positive (ALK+) non-small cell cancer (NSCLC) whose disease is resistant to crizotinib.",Takeda Pharmaceutical Company Limited,Non-Small Cell Lung Cancer,28-Apr-17,4/28/17,brigatinib,No,222,222,0,0,NCT02094573,,,,,,,1,Brineura,TRUE,,,,,,,,,,,,,,"Brineura (cerliponase alfa) is an enzyme replacement therapy for the restoration of tripeptidyl peptidase-1 (TPP1) enzyme activity in patients with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), or TPP1 deficiency, a form of Batten disease.",BioMarin Pharmaceutical Inc.,CLN2 Disease,27-Apr-17,4/27/17,cerliponase alfa,No,24,24,0,0,NCT01907087,,,,,,,1,Ingrezza,,,,,,,,,,TRUE,,,,,"Ingrezza (valbenazine) is a novel, highly-selective VMAT2 inhibitor for the treatment of tardive dyskinesia.","Neurocrine Biosciences, Inc.",Tardive Dyskinesia,11-Apr-17,4/11/17,valbenazine,No,234,156,78,0,NCT02274558,,,,,,,1,Austedo,,,,,,,,,,TRUE,,,,,Austedo (deutetrabenazine) is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of chorea associated with Huntingtonäó»s disease and the treatment of tardive dyskinesia.,Teva Pharmaceutical Industries Ltd.,"Huntington Disease, Tardive Dyskinesia",3-Apr-17,4/3/17,deutetrabenazine,No,90,45,45,0,NCT01795859,,,,,,,1,Ocrevus,,,,,,,,TRUE,,,,,,,"Ocrevus (ocrelizumab) is a humanized monoclonal antibody designed to selectively target CD20-positive B cells, a specific type of immune cell thought to be a key contributor to myelin and axonal nerve cell damage. Ocrevus is indicated as a treatment for both relapsing (RMS) and primary progressive (PPMS) forms of multiple sclerosis.","Genentech, Inc.",Multiple Sclerosis,28-Mar-17,3/28/17,ocrelizumab,No,1656,827,0,829,NCT01247324,NCT01412333,,,,,,1,Dupixent,,,,TRUE,,,,,,,,,,,"Dupixent (dupilumab) is an interleukin-4 receptor alpha antagonist indicated for the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis.","Sanofi  and Regeneron Pharmaceuticals, Inc.","Atopic Dermatitis, Asthma",28-Mar-17,3/28/17,dupilumab,No,1338,563,775,0,NCT02277743,NCT02277769,,,,,,1,Zejula,,,,,,,,TRUE,,,,,,,"Zejula (niraparib) is an oral, poly ADP-ribose polymerase (PARP) inhibitor for the treatment of patients with ovarian, fallopian tube, or primary peritoneal cancer.","Tesaro, Inc.","Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer",27-Mar-17,3/27/17,niraparib,No,553,372,181,0,NCT01847274,,,,,,,1,Bavencio,,,,,,,,TRUE,,,,,,,Bavencio (avelumab) is a programmed death ligand-1 (PD-L1) blocking antibody indicated for the treatment of patients with metastatic Merkel cell carcinoma (MCC); patients with advanced or metastatic urothelial carcinoma; and in combination with axitinib for patients with advanced renal cell carcinoma.,EMD Serono Inc.,"Merkel Cell Carcinoma, Urothelial Carcinoma, Renal Cell Carcinoma",23-Mar-17,3/23/17,avelumab,No,88,88,0,0,NCT02155647,,,,,,,1,Symproic,TRUE,,,,,,,,,,,,,,Symproic (naldemedine) is a peripherally-acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation.,Shionogi Inc.,Opioid-Induced Constipation,23-Mar-17,3/23/17,naldemedine,No,1095,549,546,0,NCT01965158,NCT01993940,,,,,,1,Xadago,,,,,,,,,,TRUE,,,,,Xadago (safinamide) is a monoamine oxidase type B (MAO-B) inhibitor indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinsonäó»s disease (PD) experiencing äóìoffäó episodes. ,Newron Pharmaceuticals S.p.A.,Parkinson's Disease,21-Mar-17,3/21/17,safinamide,No,1194,707,487,0,NCT01187966,,,,,,,1,Kisqali,,,,,,,,TRUE,,,,,,,"Kisqali (ribociclib) is an inhibitor of cyclin-dependent kinase (CDK) 4 and 6 indicated for the combination treatment of pre/perimenopausal or postmenopausal women with HR+/HER2- metastatic breast cancer.",Novartis Pharmaceuticals Corporation,Breast Cancer,13-Mar-17,3/13/17,ribociclib,No,668,334,334,0,NCT01958021,,,,,,,1,Xermelo,TRUE,,,,,,,,,,,,,,Xermelo (telotristat ethyl) is an oral tryptophan hydroxylase inhibitor indicated for use in combination with somatostatin analog (SSA) therapy for the treatment of carcinoid syndrome diarrhea in patients with metastatic neuroendocrine tumors.,"Lexicon Pharmaceuticals, Inc.",Carcinoid Syndrome Diarrhea,28-Feb-17,2/28/17,telotristat ethyl,No,90,45,45,0,NCT01677910,,,,,,,1,Siliq,,,,,,,,TRUE,,,,,,,Siliq (brodalumab) is a human anti-interleukin-17-receptor monoclonal antibody for the treatment of plaque psoriasis.,"Valeant Pharmaceuticals International, Inc.",Plaque Psoriasis,15-Feb-17,2/15/17,brodalumab,No,2915,1458,844,613,NCT01708629,NCT01708590,NCT01708603,,,,,1,Emflaza,,,,,,TRUE,,,,,,,,,Emflaza (deflazacort) is a glucocorticoid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.,"PTC Therapeutics, Inc.",Duchenne Muscular Dystrophy,9-Feb-17,2/9/17,deflazacort,No,101,51,50,0,NCT03783923,,,,,,,1,Parsabiv,,,,,,TRUE,,,,,,,,,Parsabiv (etelcalcetide) is a calcium-sensing receptor agonist indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.,Amgen Inc.,Secondary Hyperparathyroidism,7-Feb-17,2/7/17,etelcalcetide,No,1023,509,514,0,NCT01788046,,,,,,,1,Trulance,TRUE,,,,,,,,,,,,,,"Trulance (plecanatide) is a guanylate cyclase-C agonist for the treatment of chronic idiopathic constipation, and irritable bowel syndrome with constipation (IBS-C).",Synergy Pharmaceuticals Inc. ,"Constipation -- Chronic, Irritable Bowel Syndrome",19-Jan-17,1/19/17,plecanatide,No,1775,883,892,0,NCT01982240,,,,,,,1,Spinraza,,,,,,,,,TRUE,,,,,,"Spinraza (nusinersen) is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide indicated for the treatment of spinal muscular atrophy (SMA) in  pediatric and adult patients.",Biogen,Spinal Muscular Atrophy,23-Dec-16,12/23/16,nusinersen,No,82,52,30,0,,,,,,,,1,Rubraca,,,,,,,,TRUE,,,,,,,"Rubraca (rucaparib) is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated for the treatment of patients with deleterious BRCA mutation (germline and/or somatic)-associated epithelial ovarian, fallopian tube, or primary peritoneal cancer who have been treated with two or more chemotherapies; and for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. ","Clovis Oncology, Inc.",Ovarian Cancer,19-Dec-16,12/19/16,rucaparib,No,106,106,0,0,,,,,,,,1,Eucrisa,,,,TRUE,,,,,,,,,,,"Eucrisa (crisaborole) is a novel, non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor indicated for the treatment of mild-to-moderate atopic dermatitis.","Pfizer, Inc.",Atopic Dermatitis,14-Dec-16,12/14/16,crisaborole,No,1522,1016,506,0,,,,,,,,1,Zinplava,,,,,,,TRUE,,,,,,,,"Zinplava (bezlotoxumab) is a selective, fully-human, monoclonal antibody that binds to Clostridium difficile toxin B, indicated to reduce recurrence of Clostridium difficile infection (CDI) in patients 18 years of age or older.","Merck & Co., Inc.",Prevention of Clostridium Difficile Infection Recurrence,21-Oct-16,10/21/16,bezlotoxumab,No,1554,781,773,0,,,,,,,,1,Lartruvo,,,,,,,,TRUE,,,,,,,Lartruvo (olaratumab) is a platelet-derived growth factor receptor alpha (PDGFR-‘±) blocking antibody indicated in combination with doxorubicin for the treatment of patients with advanced soft tissue sarcoma (STS).,Eli Lilly and Company,Soft Tissue Sarcoma,19-Oct-16,10/19/16,olaratumab,No,133,66,0,67,,,,,,,,1,Exondys 51,,,,,,,,,TRUE,,,,,,Exondys 51 (eteplirsen) is an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping.,Sarepta Therapeutics,Duchenne Muscular Dystrophy,19-Sep-16,9/19/16,eteplirsen,No,25,21,4,0,,,,,,,Some cross-over,1,Adlyxin,TRUE,,,,,,,,,,,,,,Adlyxin (lixisenatide) is a once-daily prandial GLP-1 receptor agonist for the treatment of adults with type 2 diabetes mellitus.,Sanofi,Diabetes Type 2,27-Jul-16,7/27/16,lixisenatide,No,5079,2694,1473,912,,,,,,,,1,Xiidra,,,,,,,,,,,,,TRUE,,Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease.,Shire US Inc.,Dry Eye Disease,11-Jul-16,7/11/16,lifitegrast,No,2133,1064,1069,0,,,,,,,,1,Epclusa,,,,,,,TRUE,,,,,,,,Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A inhibitor fixed-dose combination for the treatment of chronic genotype 1-6 hepatitis C virus (HCV) infection.,"Gilead Sciences, Inc.",Chronic Hepatitis C,28-Jun-16,6/28/16,sofosbuvir and velpatasvir,No,1825,1302,116,407,,,,,,,,1,Zinbryta,,,,,,,,TRUE,,,,,,,Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing forms of multiple sclerosis (MS).,"AbbVie, Inc. and Biogen",Multiple Sclerosis,27-May-16,5/27/16,daclizumab,No,2253,1127,204,922,,,,,,,,1,Ocaliva,TRUE,,,,,,,,,,,,,,"Ocaliva (obeticholic acid) is a first-in-class farnesoid X receptor (FXR) agonist for the treatment of primary biliary cholangitis.","Intercept Pharmaceuticals, Inc.",Biliary Cirrhosis,27-May-16,5/27/16,obeticholic acid,No,216,143,73,0,,,,,,,,1,Tecentriq,,,,,,,,TRUE,,,,,,,"Tecentriq (atezolizumab) is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for use in the treatment of urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), and small cell lung cancer (SCLC).","Genentech, Inc.","Bladder Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Small Cell Lung Cancer",18-May-16,5/18/16,atezolizumab,No,310,310,0,0,,,,,,,,1,Nuplazid,,,,,,,,,,TRUE,,,,,"Nuplazid (pimavanserin) is a non-dopaminergic, selective serotonin inverse agonist (SSIA) for the treatment of psychosis associated with Parkinsonäó»s disease. ",Acadia Pharmaceuticals Inc. ,Parkinsonäó»s Disease Psychosis,29-Apr-16,4/29/16,pimavanserin,No,185,95,90,0,,,,,,,,1,Venclexta,,,,,,,,TRUE,,,,,,,Venclexta (venetoclax) is an oral B-cell lymphoma-2 (BCL-2) inhibitor indicated:,AbbVie Inc.,"Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia",11-Apr-16,4/11/16,venetoclax,No,106,106,0,0,,,,,,,,1,Defitelio,,TRUE,,,,,,,,,,,,,Defitelio (defibrotide sodium) is a deoxyribonucleic acid derivative anticoagulant for the treatment of patients with hepatic veno-occlusive disease (VOD) with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT).,Jazz Pharmaceuticals plc,Hepatic Veno-Occlusive Disease,30-Mar-16,3/30/16,defibrotide sodium,No,177,177,0,0,,,,,,,,1,Cinqair,,,,,,,,,,,,TRUE,,,Cinqair (reslizumab) is an interleukin 5 antagonist monoclonal antibody (IgG4 kappa) indicated for add-on maintenance treatment of patients with eosinophilic asthma.,Teva Pharmaceutical Industries Ltd.,Asthma,23-Mar-16,3/23/16,reslizumab,No,1657,828,829,0,,,,,,,,1,Taltz,,,,,,,,TRUE,,,,,,,"Taltz (ixekizumab) is a humanized interleukin-17A antagonist indicated for the treatment of plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.",Eli Lilly and Company,"Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis",22-Mar-16,3/22/16,ixekizumab,No,1961,1169,792,0,,,,,,,,1,Anthim,,,,,,,TRUE,,,,,,,,Anthim (obiltoxaximab) is a monoclonal antibody (mAb) anthrax antitoxin for the treatment and prevention of inhalational anthrax.,"Elusys Therapeutics, Inc.","Anthrax Prophylaxis, Inhalation Bacillus anthracis",18-Mar-16,3/18/16,obiltoxaximab,No,0,0,0,0,"Because it is not feasible or ethical to conduct controlled clinical trials in humans with inhalational anthrax, the efficacy of ANTHIM for the treatment of inhalational anthrax is based on efficacy studies in NZW rabbits and cynomolgus macaques.",,,,,,,1,Briviact,,,,,,,,,,TRUE,,,,,"Briviact (brivaracetam) is a selective, high-affinity synaptic vesicle protein 2A ligand and analog of levetiracetam indicated for the treatment of partial-onset seizures in patients with epilepsy.","UCB, Inc.",Epilepsy,19-Feb-16,2/19/16,brivaracetam,No,1256,801,455,0,,,,,,,,1,Zepatier,,,,,,,TRUE,,,,,,,,"Zepatier (elbasvir and grazoprevir) is a once-daily, single tablet, NS5A replication complex inhibitor and NS3/4A protease inhibitor combination for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections.","Merck & Co., Inc.",Chronic Hepatitis C,28-Jan-16,1/28/16,elbasvir and grazoprevir,No,1274,1059,215,0,,,,,,,,1,Zurampic,,,,,,,,,TRUE,,,,,,Zurampic (lesinurad) is a URAT1 inhibitor indicated for the combination treatment of hyperuricemia associated with gout.,"Ironwood Pharmaceuticals, Inc.",Hyperuricemia Associated with Gout,22-Dec-15,12/22/15,lesinurad,No,1213,808,405,0,,,,,,,,1,Uptravi,,TRUE,,,,,,,,,,,,,Uptravi (selexipag) is an oral prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension.,"Actelion Pharmaceuticals US, Inc.",Pulmonary Arterial Hypertension,21-Dec-15,12/21/15,selexipag,No,1156,574,582,0,,,,,,,,1,Bridion,,,,,,,,,,,,,,TRUE,Bridion (sugammadex) is a novel selective relaxant binding agent (SRBA) for the reversal of neuromuscular blockade induced by rocuronium or vecuronium.,"Merck & Co., Inc.",Reversal of Nondepolarizing Muscle Relaxants,15-Dec-15,12/15/15,sugammadex,No,346,173,0,173,,,,,,,,1,Alecensa,,,,,,,,TRUE,,,,,,,"Alecensa (alectinib) is an oral, anaplastic lymphoma kinase (ALK) inhibitor for the treatment of ALK-positive non-small cell lung cancer (NSCLC).","Genentech, Inc.",Non-Small Cell Lung Cancer,11-Dec-15,12/11/15,alectinib,No,225,225,0,0,,,,,,,,1,Kanuma,TRUE,,,,,,,,,,,,,,Kanuma (sebelipase alfa) is an enzyme replacement therapy for the treatment of lysosomal acid lipase deficiency (LAL-D).,"Alexion Pharmaceuticals, Inc. ",Lysosomal Acid Lipase Deficiency,8-Dec-15,12/8/15,sebelipase alfa,No,9,9,0,0,,,,,,,,1,Empliciti,,,,,,,,TRUE,,,,,,,Empliciti (elotuzumab) is a Signaling Lymphocyte Activation Molecule (SLAMF7)-directed immunostimulatory antibody indicated for the combination treatment of patients with multiple myeloma.,Bristol-Myers Squibb Company and AbbVie,Multiple Myeloma,30-Nov-15,11/30/15,elotuzumab,No,646,321,0,325,,,,,,,,1,Portrazza,,,,,,,,TRUE,,,,,,,Portrazza (necitumumab) is an epidermal growth factor receptor (EGFR) antagonist indicated in combination with gemcitabine and cisplatin for the treatment of patients with metastatic squamous non-small cell lung cancer. ,Eli Lilly and Company,Non-Small Cell Lung Cancer,24-Nov-15,11/24/15,necitumumab,No,1726,860,0,866,,,,,,,,1,Ninlaro,,,,,,,,TRUE,,,,,,,Ninlaro (ixazomib) is an oral proteasome inhibitor indicated for use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.,Takeda Pharmaceutical Company Limited,Multiple Myeloma,20-Nov-15,11/20/15,ixazomib,No,722,360,362,0,,,,,,,,1,Darzalex,,,,,,,,TRUE,,,,,,,Darzalex (daratumumab) is a human anti-CD38 monoclonal antibody indicated for the treatment of patients with multiple myeloma.,"Janssen Biotech, Inc.",Multiple Myeloma,16-Nov-15,11/16/15,daratumumab,No,148,148,0,0,,,,,,,,1,Tagrisso,,,,,,,,TRUE,,,,,,,"Tagrisso (osimertinib) is a tyrosine kinase inhibitor (TKI) of epidermal growth factor receptor (EGFR) indicated for the treatment of patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer.",AstraZeneca Pharmaceuticals,Non-Small Cell Lung Cancer,13-Nov-15,11/13/15,osimertinib,No,411,411,0,0,,,,,,,,1,Cotellic,,,,,,,,TRUE,,,,,,,Cotellic (cobimetinib) is a kinase inhibitor indicated for use in combination with vemurafenib for the treatment of advanced melanoma with a BRAF V600E or V600K mutation.,"Genentech, Inc.",Melanoma -- Metastatic,10-Nov-15,11/10/15,cobimetinib,No,495,247,248,0,,,,,,,,1,Genvoya,,,,,,,TRUE,,,,,,,,"Genvoya (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide or E/C/F/TAF) is an antiretroviral combination for the treatment of HIV infection.","Gilead Sciences, Inc.",HIV Infection,5-Nov-15,11/5/15,"elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide or E/C/F/TAF",No,3194,1930,0,1264,,,,,,,,1,Nucala,,,,,,,,,,,,TRUE,,,"Nucala (mepolizumab) is an interleukin-5 antagonist monoclonal antibody (IgG1 kappa) indicated for the add-on maintenance treatment of patients with severe eosinophilic asthma, and for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).",GlaxoSmithKline plc,"Asthma, Churg-Strauss Allergic Angiitis",4-Nov-15,11/4/15,mepolizumab,No,711,263,257,191,,,,,,,,1,Strensiq,TRUE,,,,,,,,,,,,,,"Strensiq (asfotase alfa) is a tissue nonspecific alkaline phosphatase  enzyme replacement therapy indicated for the treatment of patients with perinatal, infantile and juvenile-onset hypophosphatasia (HPP).","Alexion Pharmaceuticals, Inc.",Hypophosphatasia,23-Oct-15,10/23/15,asfotase alfa,No,81,81,0,0,,,,,,,,1,Yondelis,,,,,,,,TRUE,,,,,,,"Yondelis (trabectedin) is a cytotoxic antitumor agent for the treatment of unresectable or metastatic liposarcoma or leiomyosarcoma, two common subtypes of soft tissue sarcoma.","Janssen Biotech, Inc.",Soft Tissue Sarcoma,23-Oct-15,10/23/15,trabectedin,No,518,345,0,173,,,,,,,,1,Veltassa,,,,,,,,,,,,,,TRUE,Veltassa (patiromer) is an oral potassium binder for the treatment of hyperkalemia. ,"Relypsa, Inc. ",Hyperkalemia,21-Oct-15,10/21/15,patiromer,No,654,602,0,52,55 patients included in 2 trials,,,,,,,1,Praxbind,,,,,,,,,,,,,,TRUE,Praxbind (idarucizumab) is a humanized monoclonal antibody fragment (Fab) indicated as a specific reversal agent for the anticoagulant effect of dabigatran (Pradaxa).,"Boehringer Ingelheim Pharmaceuticals, Inc.",Reversal Agent for Pradaxa,16-Oct-15,10/16/15,idarucizumab,No,90,90,0,0,Note that trial was ongoing; total reflects number of patients available at time of FDA review,,,,,,,1,Aristada,,,,,,,,,,TRUE,,,,,"Aristada (aripiprazole lauroxil) is an extended-release injectable atypical antipsychotic with one-month, six-week, and two-month dosing options for the treatment of schizophrenia. ",Alkermes plc ,Schizophrenia,5-Oct-15,10/5/15,aripiprazole lauroxil,No,622,415,207,0,,,,,,,,1,Tresiba,TRUE,,,,,,,,,,,,,,Tresiba (insulin degludec) is a long-acting basal insulin analogue indicated to improve glycemic control in patients one year of age and older with diabetes mellitus.,Novo Nordisk,"Diabetes Type 1, Diabetes Type 2",25-Sep-15,9/25/15,insulin degludec,No,1084,774,0,310,,,,,,,,1,Lonsurf,,,,,,,,TRUE,,,,,,,"Lonsurf (tipiracil and trifluridine) is a thymidine phosphorylase inhibitor and nucleoside metabolic inhibitor combination indicated for the treatment of patients with previously treated metastatic colorectal cancer, and previously treated metastatic gastric or gastroesophageal junction adenocarcinoma.","Taiho Oncology, Inc.","Colorectal Cancer, Gastric Cancer",22-Sep-15,9/22/15,tipiracil and trifluridine,No,800,534,266,0,,,,,,,,1,Vraylar,,,,,,,,,,TRUE,,,,,Vraylar (cariprazine) is a dopamine D3/D2 receptor partial agonist atypical antipsychotic for the:,Allergan and Gedeon Richter plc,"Schizophrenia, Bipolar Disorder",17-Sep-15,9/17/15,cariprazine,No,1466,1024,442,0,,,,,,,,1,Xuriden,TRUE,,,,,,,,,,,,,,Xuriden (uridine triacetate) is an orally administered pyrimidine analog uridine replacement product for the treatment of patients with hereditary orotic aciduria.,Wellstat Therapeutics Corporation,Hereditary Orotic Aciduria,4-Sep-15,9/4/15,uridine triacetate,No,4,4,0,0,Plus case reports from 19 patients,,,,,,,1,Varubi,TRUE,,,,,,,,,,,,,,Varubi (rolapitant) is a substance P/neurokinin 1 (NK1) receptor antagonist indicated for use in the prevention of delayed nausea and vomiting associated with emetogenic chemotherapy.,Tesaro Inc.,Nausea/Vomiting -- Chemotherapy Induced,1-Sep-15,9/1/15,rolapitant,No,1087,544,0,543,,,,,,,,1,Repatha,,,TRUE,,,,,,,,,,,,"Repatha (evolocumab) is a monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9) indicated for the treatment of patients with heterozygous familial hypercholesterolemia; homozygous familial hypercholesterolemia; and to reduce the risk of myocardial infarction, stroke, and coronary revascularization in adults with established cardiovascular disease. ",Amgen Inc.,High Cholesterol; Prevention of Heart Attack and Stroke,27-Aug-15,8/27/15,evolocumab,No,813,558,255,0,,,,,,,,1,Addyi,,,,,TRUE,,,,,,,,,,"Addyi (flibanserin) is a non-hormonal, multifunctional serotonin agonist antagonist (MSAA) for the treatment of hypoactive sexual desire disorder in premenopausal women.","Sprout Pharmaceuticals, Inc.",Hypoactive Sexual Desire Disorder,18-Aug-15,8/18/15,flibanserin,No,2375,1177,1198,0,,,,,,,,1,Daklinza,,,,,,,TRUE,,,,,,,,Daklinza (daclatasvir) is an NS5A inhibitor indicated for use in combination with sofosbuvir for the treatment of chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection.,Bristol-Myers Squibb Company,Chronic Hepatitis C,24-Jul-15,7/24/15,daclatasvir,No,152,152,0,0,,,,,,,,1,Odomzo,,,,,,,,TRUE,,,,,,,Odomzo (sonidegib) is a hedgehog pathway inhibitor indicated for the treatment of locally advanced basal cell carcinoma (BCC).,Novartis Pharmaceuticals Corporation,Basal Cell Carcinoma,24-Jul-15,7/24/15,sonidegib,No,230,230,0,0,,,,,,,,1,Praluent,,,TRUE,,,,,,,,,,,,Praluent (alirocumab) is a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor monoclonal antibody indicated:,"Sanofi and Regeneron Pharmaceuticals, Inc.",High Cholesterol,24-Jul-15,7/24/15,alirocumab,No,3499,2324,1175,0,,,,,,,,1,Rexulti,,,,,,,,,,TRUE,,,,,Rexulti (brexpiprazole) is a serotonin-dopamine activity modulator (SDAM) for the treatment of schizophrenia and the adjunctive treatment of major depressive disorder.,"Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S",Schizophrenia; Major Depressive Disorder,10-Jul-15,7/10/15,brexpiprazole,No,980,599,381,0,,,,,,,,1,Entresto,,,TRUE,,,,,,,,,,,,Entresto (sacubitril and valsartan) is a neprilysin inhibitor and angiotensin II receptor blocker combination indicated:,Novartis Pharmaceuticals Corporation,Heart Failure,7-Jul-15,7/7/15,sacubitril and valsartan,No,8399,4187,0,4212,,,,,,,,1,Orkambi,,,,,,,,,,,,TRUE,,,Orkambi (ivacaftor and lumacaftor) is a CFTR potentiator and CFTR corrector combination for the treatment of the underlying cause of cystic fibrosis in patients 2 years and older with two copies of the F508del mutation in their CFTR gene.,Vertex Pharmaceuticals Incorporated,Cystic Fibrosis,2-Jul-15,7/2/15,ivacaftor and lumacaftor,No,740,369,371,0,,,,,,,,1,Kengreal,,TRUE,,,,,,,,,,,,,Kengreal (cangrelor) is an intravenous P2Y12 platelet inhibitor indicated for use in patients undergoing Percutaneous Coronary Intervention (PCI) to reduce the risk of periprocedural thrombotic events.,The Medicines Company,Percutaneous Coronary Intervention,22-Jun-15,6/22/15,cangrelor,No,10942,5472,0,5470,"Noted some other trials, but not part of review",,,,,,,1,Viberzi,TRUE,,,,,,,,,,,,,,Viberzi (eluxadoline) is a mu-opioid receptor agonist indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. ,"Allergan, Inc.",Irritable Bowel Syndrome,27-May-15,5/27/15,eluxadoline,No,2425,1616,809,0,,,,,,,,1,Stiolto Respimat,,,,,,,,,,,,TRUE,,,Stiolto Respimat (olodaterol and tiotropium bromide) is a long-acting beta agonist (LABA) and long-acting muscarinic antagonist (LAMA) fixed-dose combination for the treatment of chronic obstructive pulmonary disease (COPD).,"Boehringer Ingelheim Pharmaceuticals, Inc.",Chronic Obstructive Pulmonary Disease,21-May-15,5/21/15,olodaterol and tiotropium bromide,No,0,,,,,,,,,,,1,Kybella,,,,TRUE,,,,,,,,,,,Kybella (deoxycholic acid) is a cytolytic drug indicated to improve the appearance of fullness associated with submental fat (double chin).,"Allergan, Inc.",Submental Fullness,29-Apr-15,4/29/15,deoxycholic acid,No,1022,514,508,0,,,,,,,,1,Corlanor,,,TRUE,,,,,,,,,,,,Corlanor (ivabradine) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated for the treatment of chronic heart failure.,Amgen Inc.,Chronic Heart Failure,15-Apr-15,4/15/15,ivabradine,No,6505,3241,3264,0,"Noted some other trials, but not part of review",,,,,,,1,Cholbam,TRUE,,,,,,,,,,,,,,"Cholbam (cholic acid) is a bile acid preparation for the treatment of patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders (including Zellweger spectrum disorders).",Asklepion Pharmaceuticals LLC,Bile Acid Synthesis Disorders,17-Mar-15,3/17/15,cholic acid,No,62,62,0,0,,,,,,,,1,Unituxin,,,,,,,,TRUE,,,,,,,Unituxin (dinutuximab) is a chimeric monoclonal antibody used for the treatment of pediatric neuroblastoma.,United Therapeutics Corporation,Neuroblastoma,10-Mar-15,3/10/15,dinutuximab,No,226,113,0,113,,,,,,,,1,Cresemba,,,,,,,TRUE,,,,,,,,Cresemba (isavuconazonium) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis.,"Astellas Pharma US, Inc.",Invasive Aspergillosis; Invasive Mucormycosis,6-Mar-15,3/6/15,isavuconazonium,No,553,295,0,258,,,,,,,,1,Avycaz,,,,,,,TRUE,,,,,,,,"Avycaz (avibactam and ceftazidime) is a next generation, non-‘_ lactam ‘_-lactamase inhibitor and third-generation, antipseudomonal cephalosporin antibiotic combination for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, hospital-acquired bacterial pneumonia, and ventilator-associated bacterial pneumonia.",Actavis plc,"Intraabdominal Infection, Urinary Tract Infection, Pneumonia",25-Feb-15,2/25/15,avibactam and ceftazidime,No,0,0,0,0,The determination of efficacy of AVYCAZ was supported in part by the previous findings of the efficacy and safety of ceftazidime for the treatment of cIAI and cUTI. The contribution of avibactam to AVYCAZ was primarily established in vitro and in animal models of infection [,,,,,,,1,Farydak,,,,,,,,TRUE,,,,,,,Farydak (panobinostat) is a histone deacetylase inhibitor for the combination treatment of multiple myeloma.,Novartis Pharmaceuticals Corporation,Multiple Myeloma,23-Feb-15,2/23/15,panobinostat,No,768,387,381,0,,,,,,,,1,Lenvima,,,,,,,,TRUE,,,,,,,"Lenvima (lenvatinib) is a multiple receptor tyrosine kinase (RTK) inhibitor for the treatment of  thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, and endometrial carcinoma.",Eisai Inc.,"Thyroid Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma, Endometrial Carcinoma",13-Feb-15,2/13/15,lenvatinib,No,392,261,131,0,,,,,,,,1,Ibrance,,,,,,,,TRUE,,,,,,,"Ibrance (palbociclib) is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:",Pfizer Inc.,Breast Cancer,3-Feb-15,2/3/15,palbociclib,No,165,84,0,81,,,,,,,,1,Natpara,,,,,,TRUE,,,,,,,,,Natpara (parathyroid hormone) is recombinant human parathyroid hormone 1-84 indicated to control hypocalcemia in patients with hypoparathyroidism.,"NPS Pharmaceuticals, Inc. ",Hypoparathyroidism,23-Jan-15,1/23/15,parathyroid hormone,No,124,84,40,0,,,,,,,,1,Cosentyx,,,,,,,,TRUE,,,,,,,"Cosentyx (secukinumab) is a selective interleukin-17A (IL-17A) inhibitor for the treatment of plaque psoriasis, ankylosing spondylitis, and psoriatic arthritis.",Novartis Pharmaceuticals Corporation,"Plaque Psoriasis, Ankylosing Spondylitis, Psoriatic Arthritis",21-Jan-15,1/21/15,secukinumab,No,2400,1383,694,323,,,,,,,,1,Savaysa,,TRUE,,,,,,,,,,,,,"Savaysa (edoxaban) is an oral, once-daily factor Xa inhibitor anticoagulant indicated for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and for the treatment of deep vein thrombosis, and pulmonary embolism.",Daiichi Sankyo Company,"Prevention of Thromboembolism in Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism",8-Jan-15,1/8/15,edoxaban,No,21026,14014,0,7012,,,,,,,,1,Opdivo,,,,,,,,TRUE,,,,,,,"Opdivo (nivolumab) is a programmed death receptor-1 (PD-1) blocking antibody for the treatment of advanced melanoma, advanced non-small cell lung cancer, advanced small cell lung cancer, advanced renal cell carcinoma, classical Hodgkin lymphoma, advanced squamous cell carcinoma of the head and neck, urothelial carcinoma, MSI-H or dMMR metastatic colorectal cancer, and hepatocellular carcinoma.",Bristol-Myers Squibb Company,"Melanoma -- Metastatic, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Hodgkin's Disease, Head and Neck Cancer, Urothelial Carcinoma, Colorectal Cancer, Hepatocellular Carcinoma, Small Cell Lung Cancer",22-Dec-14,12/22/14,nivolumab,No,509,372,0,137,,,,,,,,1,Viekira Pak,,,,,,,TRUE,,,,,,,,"Viekira Pak (ombitasvir/paritaprevir/ritonavir with dasabuvir) is an NS5A inhibitor, NS3/4A protease inhibitor and CYP3A inhibitor combination co-packaged with a non-nucleoside NS5B palm polymerase inhibitor for the treatment of patients with genotype 1 chronic hepatitis C virus (HCV) infection.",AbbVie Inc.,Chronic Hepatitis C,19-Dec-14,12/19/14,ombitasvir/paritaprevir/ritonavir with dasabuvir,No,2308,2053,255,0,,,,,,,,1,Lynparza,,,,,,,,TRUE,,,,,,,Lynparza capsules (discontinued) and tablets are indicated for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.,AstraZeneca,"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Breast Cancer",19-Dec-14,12/19/14,discontinued,No,137,137,0,0,,,,,,,,1,Rapivab,,,,,,,TRUE,,,,,,,,Rapivab (peramivir) is an influenza virus neuraminidase inhibitor indicated for the treatment of acute uncomplicated influenza.,"BioCryst Pharmaceuticals, Inc.",Influenza,19-Dec-14,12/19/14,peramivir,No,300,199,101,0,Had to look at FDA review,,,,,,,1,Zerbaxa,,,,,,,TRUE,,,,,,,,Zerbaxa (ceftolozane and tazobactam) is a cephalosporin and beta-lactamase inhibitor combination for the treatment of:,"Cubist Pharmaceuticals, Inc.","Intraabdominal Infection, Urinary Tract Infection, Pneumonia",19-Dec-14,12/19/14,ceftolozane and tazobactam,No,1402,664,0,738,,,,,,,,1,Xtoro,,,,,,,TRUE,,,,,,,,"Xtoro (finafloxacin otic suspension) is a fluoroquinolone antimicrobial for the treatment of acute otitis externa, commonly known as swimmeräó»s ear.","Alcon Laboratories, Inc.",Otitis Externa,17-Dec-14,12/17/14,finafloxacin otic suspension,No,686,344,342,0,,,,,,,,1,Blincyto,,,,,,,,TRUE,,,,,,,"Blincyto (blinatumomab) is a bispecific CD19-directed CD3 T-cell engager indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), and minimal residual disease (MRD)-positive B-cell precursor ALL.",Amgen Inc.,Acute Lymphoblastic Leukemia,3-Dec-14,12/3/14,blinatumomab,No,185,185,0,0,,,,,,,,1,Ofev,,,,,,,,TRUE,,,,,,,"Ofev (nintedanib) is a small molecule tyrosine kinase inhibitor (TKI) indicated for the treatment of idiopathic pulmonary fibrosis, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).","Boehringer Ingelheim Pharmaceuticals, Inc.",Idiopathic Pulmonary Fibrosis; Sclerosis-Associated Interstitial Lung Disease,15-Oct-14,10/15/14,nintedanib,No,1228,722,506,0,,,,,,,,1,Esbriet,,,,,,,,TRUE,,,,,,,Esbriet (pirfenidone) is a TGF-beta synthesis inhibitor for the treatment of patients with idiopathic pulmonary fibrosis (IPF).,"InterMune, Inc.",Idiopathic Pulmonary Fibrosis,15-Oct-14,10/15/14,pirfenidone,No,1334,710,624,0,,,,,,,,1,Harvoni,,,,,,,TRUE,,,,,,,,"Harvoni (ledipasvir and sofosbuvir) is a fixed-dose combination of ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir, an HCV nucleotide analog NS5B polymerase inhibitor, indicated for the treatment of chronic hepatitis C virus (HCV) in adults and pediatric patients 3 years of age and older:","Gilead Sciences, Inc.",Chronic Hepatitis C,10-Oct-14,10/10/14,ledipasvir and sofosbuvir,No,863,863,0,0,,,,,,,,1,Akynzeo,TRUE,,,,,,,,,,,,,,Akynzeo (netupitant and palonosetron) is a substance P/neurokinin 1 (NK1) receptor antagonist and serotonin-3 (5-HT3) receptor antagonist fixed-dose combination indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV).,Helsinn Group,Nausea/Vomiting -- Chemotherapy Induced,10-Oct-14,10/10/14,netupitant and palonosetron,No,2030,1169,0,861,Plus one other trial that was supportive,,,,,,,1,Trulicity,TRUE,,,,,,,,,,,,,,Trulicity (dulaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes.,Eli Lilly and Company,Diabetes Type 2,18-Sep-14,9/18/14,dulaglutide,No,4446,2791,280,1375,,,,,,,,1,Movantik,TRUE,,,,,,,,,,,,,,Movantik (naloxegol) is a peripherally-acting mu-opioid receptor antagonist indicated for the treatment of opioid-induced constipation.,AstraZeneca Pharmaceuticals LP,Opioid-Induced Constipation,16-Sep-14,9/16/14,naloxegol,No,1337,891,446,0,,,,,,,,1,Keytruda,,,,,,,,TRUE,,,,,,,"Keytruda (pembrolizumab) is a human PD-1 (programmed death receptor-1)-blocking antibody indicated for the treatment of melanoma, non-small cell lung cancer, small cell lung cancer, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, urothelial carcinoma, microsatellite instability-high cancer, gastric cancer, esophageal cancer, cervical cancer, hepatocellular carcinoma, Merkel cell carcinoma, renal cell carcinoma, and endometrial carcinoma.","Merck & Co., Inc.","Melanoma -- Metastatic, Non-Small Cell Lung Cancer, Head and Neck Cancer, Hodgkin's Disease, Urothelial Carcinoma, Gastric Cancer, Cervical Cancer, Hepatocellular Carcinoma, Merkel Cell Carcinoma, Renal Cell Carcinoma, Small Cell Lung Cancer, Esophageal Carcinoma, Endometrial Carcinoma",4-Sep-14,9/4/14,pembrolizumab,No,173,173,0,0,,,,,,,,1,Cerdelga,TRUE,,,,,,,,,,,,,,Cerdelga (eliglustat) is a glucosylceramide synthase inhibitor indicated for the long-term treatment of adult patients with Gaucher disease type 1.,Genzyme Corporation,Gaucher Disease,19-Aug-14,8/19/14,eliglustat,No,186,119,67,0,,,,,,,,1,Plegridy,,,,,,,,TRUE,,,,,,,Plegridy (peginterferon beta-1a) is a pegylated interferon beta indicated for the treatment of patients with relapsing forms of multiple sclerosis.,Biogen Idec,Multiple Sclerosis,15-Aug-14,8/15/14,peginterferon beta-1a,No,1012,512,500,0,,,,,,,,1,Belsomra,,,,,,,,,,TRUE,,,,,Belsomra (suvorexant) is an orexin receptor antagonist for use in patients with difficulty falling or staying asleep (insomnia).,"Merck, Sharpe & Dohme Corp.",Insomnia,13-Aug-14,8/13/14,suvorexant,No,1260,493,767,0,,,,,,,,1,Orbactiv,,,,,,,TRUE,,,,,,,,Orbactiv (oritavancin) is a semi-synthetic lipoglycopeptide antibiotic for the treatment of acute bacterial skin and skin structure infections (ABSSSI).,The Medicines Company,Skin and Structure Infection,6-Aug-14,8/6/14,oritavancin,No,1959,978,0,981,,,,,,,,1,Jardiance,TRUE,,,,,,,,,,,,,,"Jardiance (empagliflozin) is a sodium glucose co-transporter-2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, and to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.","Boehringer Ingelheim Pharmaceuticals, Inc.",Diabetes Type 2,1-Aug-14,8/1/14,empagliflozin,No,4800,3025,995,780,Numbers for one trial weren't perfect; might be missing some placebo patients.,,,,,,,1,Striverdi Respimat,,,,,,,,,,,,TRUE,,,"Striverdi Respimat (olodaterol) is a once-daily, long-acting beta-agonist (LABA) for the maintenance treatment of chronic obstructive pulmonary disease (COPD).",Boehringer Ingelheim Pharmaceuticals Inc.,Chronic Obstructive Pulmonary Disease,31-Jul-14,7/31/14,olodaterol,No,4230,2451,1171,608,,,,,,,,1,Zydelig,,,,,,,,TRUE,,,,,,,"Zydelig (idelalisib) is a phosphoinositide 3-kinase (PI3K) delta inhibitor for the treatment of chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma, and relapsed small lymphocytic lymphoma.","Gilead Sciences, Inc.","non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma",23-Jul-14,7/23/14,idelalisib,No,318,208,110,0,,,,,,,,1,Kerydin,,,,TRUE,,,,,,,,,,,Kerydin (tavaborole) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails.,Anacor Pharmaceuticals,Onychomycosis -- Toenail,7-Jul-14,7/7/14,tavaborole,No,1194,795,399,0,,,,,,,,1,Beleodaq,,,,,,,,TRUE,,,,,,,Beleodaq (belinostat) is a histone deacetylase (HDAC) inhibitor for the treatment of peripheral T-cell lymphoma (PTCL).,"Spectrum Pharmaceuticals, Inc.",Peripheral T-cell Lymphoma,3-Jul-14,7/3/14,belinostat,No,120,120,0,0,,,,,,,,1,Sivextro,,,,,,,TRUE,,,,,,,,Sivextro (tedizolid phosphate) is an oxazolidinone antibiotic drug indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI).,"Cubist Pharmaceuticals, Inc.",Skin and Structure Infection,20-Jun-14,6/20/14,tedizolid phosphate,No,1315,655,0,660,,,,,,,,1,Jublia,,,,TRUE,,,,,,,,,,,Jublia (efinaconazole) is a topical triazole antifungal for the treatment of onychomycosis of the toenails.,"Valeant Pharmaceuticals International, Inc.",Onychomycosis -- Toenail,6-Jun-14,6/6/14,efinaconazole,No,1651,1236,415,0,,,,,,,,1,Dalvance,,,,,,,TRUE,,,,,,,,"Dalvance (dalbavancin) is a second generation lipoglycopeptide antibiotic for the treatment of adult patients with complicated skin and skin structure infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).","Allergan, Inc.",Skin and Structure Infection,23-May-14,5/23/14,dalbavancin,No,1312,659,0,653,,,,,,,,1,Entyvio,,,,,,,,TRUE,,,,,,,Entyvio (vedolizumab) is an integrin receptor antagonist for the treatment of Crohn's disease and ulcerative colitis. ,Takeda Pharmaceutical Company Limited,"Crohn's Disease -- Acute, Ulcerative Colitis",20-May-14,5/20/14,vedolizumab,No,1612,879,733,0,,,,,,,,1,Zontivity,,TRUE,,,,,,,,,,,,,Zontivity (vorapaxar) is a protease-activated receptor-1 (PAR-1) antagonist for the prevention of cardiovascular events in high risk patients.,Merck,Cardiovascular Risk Reduction,8-May-14,5/8/14,vorapaxar,No,20170,10080,10090,0,,,,,,,,1,Zykadia,,,,,,,,TRUE,,,,,,,Zykadia (ceritinib) is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer.,Novartis Pharmaceuticals Corporation,Non-Small Cell Lung Cancer,29-Apr-14,4/29/14,ceritinib,No,163,163,0,0,,,,,,,,1,Sylvant,,,,,,,,TRUE,,,,,,,Sylvant (siltuximab) is an interleukin-6 (IL-6) antagonist indicated for the treatment of patients with multicentric Castlemanäó»s disease.,"Janssen Research & Development, LLC",Multicentric Castleman's Disease,22-Apr-14,4/22/14,siltuximab,No,79,53,26,0,,,,,,,,1,Cyramza,,,,,,,,TRUE,,,,,,,Cyramza (ramucirumab) is a human vascular endothelial growth factor receptor 2 (VEGFR2) antagonist indicated:,Eli Lilly and Company,"Gastric Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Hepatocellular Carcinoma",21-Apr-14,4/21/14,ramucirumab,No,355,238,117,0,,,,,,,,1,Tanzeum,TRUE,,,,,,,,,,,,,,Tanzeum (albiglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes.,GlaxoSmithKline (GSK) plc,Diabetes Type 2,15-Apr-14,4/15/14,albiglutide,No,4840,2339,463,2038,,,,,,,,1,Otezla,,,,,,,,TRUE,,,,,,,"Otezla (apremilast) is a phosphodiesterase 4 (PDE4) inhibitor indicated for the treatment of psoriatic arthritis, plaque psoriasis, and oral ulcers associated with Behí_etäó»s Disease.",Celgene Corporation,"Psoriatic Arthritis, Plaque Psoriasis, Behcet's Disease",21-Mar-14,3/21/14,apremilast,No,993,497,496,0,,,,,,,,1,Impavido,,,,,,,,TRUE,,,,,,,Impavido (miltefosine) is an oral alkylphosphocholine antiparasitic for the treatment of leishmaniasis.,Paladin Labs Inc. ,Leishmaniasis,19-Mar-14,3/19/14,miltefosine,No,610,467,44,99,,,,,,,,1,Myalept,TRUE,,,,,,,,,,,,,,Myalept (metreleptin) is a leptin analog indicated to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.,"Amylin Pharmaceuticals, Inc.",Lipodystrophy,24-Feb-14,2/24/14,metreleptin,No,48,48,0,0,,,,,,,,1,Northera,,,TRUE,,,,,,,,,,,,Northera (droxidopa) is an orally active synthetic precursor of norepinephrine indicated for the treatment of neurogenic orthostatic hypotension.,"Chelsea Therapeutics International, Ltd.",Neurogenic Orthostatic Hypotension,18-Feb-14,2/18/14,droxidopa,No,338,170,168,0,,,,,,,,1,Vimizim,TRUE,,,,,,,,,,,,,,Vimizim (elosufase alfa) is an enzyme replacement therapy for patients with Mucopolysaccharidosis Type IVA (Morquio A syndrome).,BioMarin Pharmaceutical Inc.,Mucopolysaccharidosis Type IVA,14-Feb-14,2/14/14,elosufase alfa,No,176,117,59,0,,,,,,,,1,Hetlioz,,,,,,,,,,TRUE,,,,,Hetlioz (tasimelteon) is a melatonin receptor agonist for the treatment of Non-24-Hour Disorder in the totally blind.,Vanda Pharmaceuticals Inc.,Non-24-Hour Disorder,31-Jan-14,1/31/14,tasimelteon,No,124,62,62,0,,,,,,,,1,Farxiga,TRUE,,,,,,,,,,,,,,Farxiga (dapagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated:,AstraZeneca,Diabetes Type 2,8-Jan-14,1/8/14,dapagliflozin,No,2876,1844,1032,0,,,,,,,,1,Anoro Ellipta,,,,,,,,,,,,TRUE,,,Anoro Ellipta (umeclidinium bromide and vilanterol) is a long-acting muscarinic antagonist (LAMA) and long-acting beta2 agonist (LABA) combination for the treatment of COPD.,"GlaxoSmithKline plc (GSK) and Theravance, Inc.",Chronic Obstructive Pulmonary Disease,18-Dec-13,12/18/13,umeclidinium bromide and vilanterol,No,5748,4449,876,423,,,,,,,,1,Sovaldi,,,,,,,TRUE,,,,,,,,Sovaldi (sofosbuvir) is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of:,Gilead Sciences,Chronic Hepatitis C,6-Dec-13,12/6/13,sofosbuvir,No,1781,1467,71,243,,,,,,,,1,Olysio,,,,,,,TRUE,,,,,,,,Olysio (simeprevir) is a protease inhibitor for the treatment of chronic hepatitis C virus infection.,"Janssen Research & Development, LLC",Chronic Hepatitis C,22-Nov-13,11/22/13,simeprevir,No,1442,979,463,0,,,,,,,,1,Luzu,,,,TRUE,,,,,,,,,,,"Luzu (luliconazole) Cream  is an azole antifungal indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis. ","Valeant Pharmaceuticals International, Inc.","Tinea Corporis, Tinea Pedis, Tinea Cruris",14-Nov-13,11/14/13,luliconazole,No,423,213,210,0,,,,,,,,1,Imbruvica,,,,,,,,TRUE,,,,,,,"Imbruvica (ibrutinib) is an oral Bruton's tyrosine kinase (BTK) inhibitor for the treatment of mantle cell lymphoma, chronic lymphocytic leukemia, Waldenstrí_mäó»s macroglobulinemia, small lymphocytic lymphoma, marginal zone lymphoma, and chronic graft versus host disease.","Janssen Biotech, Inc.",Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia; Waldenstrí_mäó»s Macroglobulinemia; Small Lymphocytic Lymphoma; Marginal Zone Lymphoma; Chronic Graft Versus Host Disease,13-Nov-13,11/13/13,ibrutinib,No,111,111,0,0,,,,,,,,1,Aptiom,,,,,,,,,,TRUE,,,,,Aptiom (eslicarbazepine acetate) is a voltage-gated sodium channel blocker for the treatment of partial-onset seizures in patients with epilepsy.,Sunovion Pharmaceuticals Inc.,"Epilepsy, Seizures",8-Nov-13,11/8/13,eslicarbazepine acetate,No,1133,727,406,0,,,,,,,,1,Gazyva,,,,,,,,TRUE,,,,,,,Gazyva (obinutuzumab) is a CD20-directed cytolytic antibody indicated for the combination treatment of patients with chronic lymphocytic leukemia and follicular lymphoma.,Genentech,"Chronic Lymphocytic Leukemia, Follicular Lymphoma",1-Nov-13,11/1/13,obinutuzumab,No,356,238,0,118,,,,,,,,1,Opsumit,,,TRUE,,,,,,,,,,,,Opsumit (macitentan) is a dual endothelin receptor antagonist for the treatment of patients with pulmonary arterial hypertension.,Actelion Pharmaceuticals Ltd.,Pulmonary Hypertension,18-Oct-13,10/18/13,macitentan,No,742,492,250,0,,,,,,,,1,Novoeight,,TRUE,,,,,,,,,,,,,Novoeight (turoctocog alfa) is an antihemophilic factor (recombinant) indicated for use in adults and children with hemophilia A.,Novo Nordisk,Hemophilia A,15-Oct-13,10/15/13,turoctocog alfa,No,213,213,0,0,,,,,,,,1,Adempas,,,TRUE,,,,,,,,,,,,Adempas (riociguat) is an oral soluble guanylate cyclase (sGC) stimulator for the treatment of pulmonary hypertension.,Bayer HealthCare Pharmaceuticals Inc.,Pulmonary Hypertension,8-Oct-13,10/8/13,riociguat,No,616,490,126,0,,,,,,,,1,Duavee,,,,,TRUE,,,,,,,,,,"Duavee (bazedoxifene and conjugated estrogens) is an estrogen agonist/antagonist and conjugated estrogens combination indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause, and prevention of postmenopausal osteoporosis in women with an intact uterus.",Pfizer Inc.,"Postmenopausal Symptoms, Prevention of Osteoporosis",3-Oct-13,10/3/13,bazedoxifene and conjugated estrogens,No,686,377,309,0,,,,,,,,1,Trintellix,,,,,,,,,,TRUE,,,,,Trintellix (vortioxetine) is a multimodal antidepressant for the treatment of major depressive disorder (MDD).,Takeda Pharmaceutical Company Limited and H. Lundbeck A/S,Depression,30-Sep-13,9/30/13,vortioxetine,No,2092,1237,855,0,,,,,,,,1,Tivicay,,,,,,,TRUE,,,,,,,,Tivicay (dolutegravir) is an integrase inhibitor indicated for use in combination with other antiretroviral (ARV) agents for the treatment of HIV-1.,ViiV Healthcare,HIV Infection,12-Aug-13,8/12/13,dolutegravir,No,1641,817,0,824,,,,,,,,1,Gilotrif,,,,,,,,TRUE,,,,,,,Gilotrif (afatinib) is a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC).,Boehringer Ingelheim Pharmaceuticals Inc.,Non-Small Cell Lung Cancer,12-Jul-13,7/12/13,afatinib,No,345,230,0,115,,,,,,,,1,Rixubis,,TRUE,,,,,,,,,,,,,"Rixubis (coagulation factor IX, recombinant) is an antihemophilic factor indicated for the control and prevention of bleeding episodes in adults with hemophilia B.",Baxter International Inc.,Hemophilia B,26-Jun-13,6/26/13,"coagulation factor IX, recombinant",No,73,73,0,0,,,,,,,,1,Tafinlar,,,,,,,,TRUE,,,,,,,Tafinlar (dabrafenib) is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.,GlaxoSmithKline,"Melanoma -- Metastatic, Non-Small Cell Lung Cancer, Thyroid Cancer",29-May-13,5/29/13,dabrafenib,No,389,326,0,63,,,,,,,,1,Mekinist,,,,,,,,TRUE,,,,,,,Mekinist (trametinib) is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test.,GlaxoSmithKline,"Melanoma -- Metastatic, Non-Small Cell Lung Cancer, Thyroid Cancer",29-May-13,5/29/13,trametinib,No,322,214,0,108,,,,,,,,1,Xofigo,,,,,,,,TRUE,,,,,,,Xofigo (radium 223 dichloride) is an alpha particle-emitting radioactive therapeutic agent indicated for the treatment of patients with castration-resistant prostate cancer.,Bayer HealthCare Pharmaceuticals Inc.,Prostate Cancer,15-May-13,5/15/13,radium 223 dichloride,No,921,614,307,0,,,,,,,,2,Breo Ellipta,,,,TRUE,,,,,,,,TRUE,,,Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid/long-acting beta2 agonist (LABA) combination indicated for the treatment of patients with chronic obstructive pulmonary disease (COPD) and asthma.,"GlaxoSmithKline plc (GSK) and Theravance, Inc.","Chronic Obstructive Pulmonary Disease, Asthma",10-May-13,5/10/13,fluticasone and vilanterol,No,5106,794,395,3917,,,,,,,,1,Invokana,TRUE,,,,,,,,,,,,,,Invokana (canagliflozin) is a selective sodium glucose co-transporter 2 (SGLT2) inhibitor indicated:,"Janssen Research & Development, LLC","Diabetes Type 2, Cardiovascular Risk Reduction, Diabetic Nephropathy",29-Mar-13,3/29/13,canagliflozin,No,6236,4165,1211,860,,,,,,,,1,Tecfidera,,,,,,,,TRUE,,,,,,,Tecfidera (dimethyl fumarate) is an oral Nrf2 pathway activator for the treatment of relapsing forms of multiple sclerosis.,Biogen Idec,Multiple Sclerosis,27-Mar-13,3/27/13,dimethyl fumarate,No,1540,769,771,0,,,,,,,,1,Osphena,,,,,TRUE,,,,,,,,,,"Osphena (ospemifene) is an estrogen agonist/antagonist indicated for the treatment of symptoms of vulvar and vaginal atrophy due to menopause, including severe dyspareunia and moderate to severe vaginal dryness.",Duchesnay Inc.,"Dyspareunia, Atrophic Vaginitis",26-Feb-13,2/26/13,ospemifene,No,2180,1384,796,0,,,,,,,,1,Kadcyla,,,,,,,,TRUE,,,,,,,"Kadcyla (ado-trastuzumab emtansine) is a HER2-targeted antibody and microtubule inhibitor conjugate indicated for the treatment of patients with HER2-positive, metastatic breast cancer.","Genentech, Inc.",Breast Cancer,22-Feb-13,2/22/13,ado-trastuzumab emtansine,No,991,495,0,496,,,,,,,,1,Pomalyst,,,,,,,,TRUE,,,,,,,Pomalyst (pomalidomide) is a thalidomide analogue indicated for the treatment of patients with multiple myeloma.,Celgene Corporation,Multiple Myeloma,8-Feb-13,2/8/13,pomalidomide,No,221,221,0,0,,,,,,,,1,Kynamro,,,TRUE,,,,,,,,,,,,Kynamro (mipomersen) is an oligonucleotide inhibitor of apolipoprotein B-100 synthesis indicated for the treatment of patients with homozygous familial hypercholesterolemia.,Kastle Therapeutics,Homozygous Familial Hypercholesterolemia,29-Jan-13,1/29/13,mipomersen,No,51,34,17,0,,,,,,,,1,Nesina,TRUE,,,,,,,,,,,,,,Nesina (alogliptin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes.,Takeda Pharmaceutical Company Limited ,Diabetes Type 2,25-Jan-13,1/25/13,alogliptin,No,4227,2381,712,1134,,,,,,,,1,Mytesi,TRUE,,,,,,,,,,,,,,Mytesi (crofelemer) is a proanthocyanidin oligomer indicated to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy.,"Napo Pharmaceuticals, Inc.",Diarrhea,31-Dec-12,12/31/12,crofelemer,No,749,518,231,0,,,,,,,,1,Sirturo,,,,,,,TRUE,,,,,,,,Sirturo (bedaquiline) is an oral diarylquinoline antimycobacterial drug indicated for the treatment of pulmonary multi-drug resistant tuberculosis.,"Janssen Research & Development, LLC",Tuberculosis -- Resistant,28-Dec-12,12/28/12,bedaquiline,No,207,102,105,0,,,,,,,,1,Eliquis,,TRUE,,,,,,,,,,,,,"Eliquis (apixaban) is a factor Xa inhibitor anticoagulant indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and for the prophylaxis of deep vein thrombosis (DVT) in patients who have undergone hip or knee replacement surgery. ",Aegerion Pharmaceuticals Inc.,Homozygous Familial Hypercholesterolemia,21-Dec-12,12/21/12,apixaban,No,23799,11927,0,11872,,,,,,,,1,Gattex,TRUE,,,,,,,,,,,,,,Gattex (teduglutide) is a recombinant analog of human glucagon-like peptide 2 for the treatment of short bowel syndrome in adults and pediatric patients one year of age and older.,Biotest Pharmaceuticals Corporation,Primary Immunodeficiency Syndrome,21-Dec-12,12/21/12,teduglutide,No,170,111,59,0,,,,,,,,1,Juxtapid,,,TRUE,,,,,,,,,,,,Juxtapid (lomitapide) is a microsomal triglyceride transfer protein inhibitor indicated for the treatment of patients with homozygous familial hypercholesterolemia.,Cangene Corporation,Varicella-Zoster,20-Dec-12,12/20/12,lomitapide,No,29,29,0,0,,,,,,,,1,Iclusig,,,,,,,,TRUE,,,,,,,Iclusig (ponatinib) is a kinase inhibitor  for the treatment of chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).,"Ariad Pharmaceuticals, Inc.","Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia",14-Dec-12,12/14/12,ponatinib,No,444,444,0,0,,,,,,,,1,Signifor,,,,,,TRUE,,,,,,,,,Signifor (pasireotide) is a multireceptor targeting somatostatin analog for the treatment of patients with Cushing's disease.,GlaxoSmithKline,Inhalation Bacillus anthracis,14-Dec-12,12/14/12,pasireotide,No,162,162,0,0,,,,,,,,1,Cometriq,,,,,,,,TRUE,,,,,,,"Cometriq (cabozantinib) is a kinase inhibitor indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer.","Exelixis, Inc.",Thyroid Cancer,29-Nov-12,11/29/12,cabozantinib,No,330,219,111,0,,,,,,,,1,Xeljanz,,,,,,,,TRUE,,,,,,,"Xeljanz (tofacitinib) is an oral Janus kinase (JAK) inhibitor for the treatment of adult patients with moderately to severely active rheumatoid arthritis, active psoriatic arthritis, and moderately to severely active ulcerative colitis.",Pfizer Inc.,"Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis",6-Nov-12,11/6/12,tofacitinib,No,3322,2437,681,204,,,,,,,,1,Synribo,,,,,,,,TRUE,,,,,,,Synribo (omacetaxine mepesuccinate) is a first-in-class small molecule drug for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia.,Teva Pharmaceuticals,Chronic Myelogenous Leukemia,26-Oct-12,10/26/12,omacetaxine mepesuccinate,No,111,111,0,0,,,,,,,,1,Fycompa,,,,,,,,,,TRUE,,,,,"Fycompa (perampanel) is a non-competitive AMPA glutamate receptor antagonist indicated for the treatment of partial-onset seizures, and as adjunctive therapy in the treatment of primary generalized tonic-clonic (PGTC) seizures in patients with epilepsy.",Eisai Inc.,"Epilepsy, Seizures",22-Oct-12,10/22/12,perampanel,No,1480,1038,442,0,,,,,,,,1,Jetrea,,,,,,,,,,,,,TRUE,,Jetrea (ocriplasmin) is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion.,ThromboGenics NV,Vitreomacular Adhesion,17-Oct-12,10/17/12,ocriplasmin,No,652,464,188,0,,,,,,,,1,Stivarga,,,,,,,,TRUE,,,,,,,"Stivarga (regorafenib) is an oral multi-kinase inhibitor for the treatment of patients with metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma.",Bayer HealthCare Pharmaceuticals Inc.,"Colorectal Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma",27-Sep-12,9/27/12,regorafenib,No,760,505,255,0,,,,,,,,1,Aubagio,,,,,,,,TRUE,,,,,,,Aubagio (teriflunomide) is an oral pyrimidine synthesis inhibitor indicated for the treatment of patients with relapsing forms of multiple sclerosis.,Sanofi,Multiple Sclerosis,12-Sep-12,9/12/12,teriflunomide,No,1088,725,363,0,,,,,,,,1,Bosulif,,,,,,,,TRUE,,,,,,,"Bosulif (bosutinib) is a kinase inhibitor indicated for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CML). ",Pfizer Inc.,Chronic Myelogenous Leukemia,4-Sep-12,9/4/12,bosutinib,No,546,546,0,0,,,,,,,,1,Xtandi,,,,,,,,TRUE,,,,,,,"Xtandi (enzalutamide) is an androgen receptor inhibitor indicated for the treatment of patients with castration-resistant prostate cancer, and metastatic castration-sensitive prostate cancer.",Astellas Pharma Inc.,Prostate Cancer,31-Aug-12,8/31/12,enzalutamide,No,1199,800,399,0,,,,,,,,1,Linzess,TRUE,,,,,,,,,,,,,,Linzess (linaclotide) is a guanylate cyclase-C agonist indicated in adults for treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).,"Allergan, Inc.","Irritable Bowel Syndrome, Constipation -- Chronic",30-Aug-12,8/30/12,linaclotide,No,2458,1236,1222,0,,,,,,,,1,Stribild,,,,,,,,,,,,,,TRUE,"Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is a complete once-daily single tablet regimen for HIV-1 infection for treatment-naí¿ve adults. ","Gilead Sciences, Inc.",HIV Infection,27-Aug-12,8/27/12,"cobicistat, elvitegravir, emtricitabine and tenofovir",No,1408,701,0,707,,,,,,,,1,Zaltrap,,,,,,,,TRUE,,,,,,,Zaltrap (ziv-aflibercept) is an angiogenesis inhibitor for the combination treatment of patients with metastatic colorectal cancer.,"Sanofi and Regeneron Pharmaceuticals, Inc.",Colorectal Cancer,3-Aug-12,8/3/12,ziv-aflibercept,No,1226,612,614,0,,,,,,,,1,Tudorza,,,,,,,,,,,,TRUE,,,"Tudorza Pressair (aclidinium bromide inhalation powder) is an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. ","Allergan, Inc.",Chronic Obstructive Pulmonary Disease,23-Jul-12,7/23/12,aclidinium bromide inhalation powder,No,1276,636,640,0,,,,,,,,1,Kyprolis,,,,,,,,TRUE,,,,,,,Kyprolis (carfilzomib) is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma.,Amgen Inc.,Multiple Myeloma,20-Jul-12,7/20/12,carfilzomib,No,266,266,0,0,,,,,,,,1,Prepopik,TRUE,,,,,,,,,,,,,,"Prepopik (sodium picosulfate, magnesium oxide and citric acid) is a stimulant laxative and osmotic laxative combination indicated for cleansing of the colon as a preparation for colonoscopy in adults.",Ferring Pharmaceuticals,Bowel Preparation,16-Jul-12,7/16/12,"sodium picosulfate, magnesium oxide and citric acid",No,1195,598,0,597,,,,,,,,1,Myrbetriq,,,,,TRUE,,,,,,,,,,"Myrbetriq (mirabegron) is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.",Astellas Pharma Inc.,Overactive Bladder,28-Jun-12,6/28/12,mirabegron,No,2007,1129,878,0,,,,,,,,1,Belviq,TRUE,,,,,,,,,,,,,,"Belviq (lorcaserin) is a serotonin 2C receptor agonist indicated for chronic weight management in adults who are obese, or overweight and who have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.","Arena Pharmaceuticals, Inc.",Obesity,27-Jun-12,6/27/12,lorcaserin,No,6635,3349,3286,0,,,,,,,,1,Perjeta,,,,,,,,TRUE,,,,,,,Perjeta (pertuzumab) is a humanized monoclonal antibody indicated for the treatment of HER2-positive breast cancer.,Genentech,Breast Cancer,8-Jun-12,6/8/12,pertuzumab,No,808,402,406,0,,,,,,,,1,Elelyso,TRUE,,,,,,,,,,,,,,Elelyso (taliglucerase alfa) is a plant-cell expressed recombinant form of glucocerebrosidase for the treatment of Gaucher disease.,"Protalix BioTherapeutics, Inc.",Gaucher Disease,1-May-12,5/1/12,taliglucerase alfa,No,56,56,0,0,,,,,,,,1,Stendra,,,,,TRUE,,,,,,,,,,Stendra (avanafil) is a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED).,"Vivus, Inc.",Erectile Dysfunction,27-Apr-12,4/27/12,avanafil,No,1001,719,282,0,,,,,,,,1,Omontys,,TRUE,,,,,,,,,,,,,Omontys (peginesatide) an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.,"Affymax, Inc. and Takeda Pharmaceutical Company Limited",Anemia Associated with Chronic Renal Failure,27-Mar-12,3/27/12,peginesatide,No,1608,1066,0,542,,,,,,,,1,Surfaxin,,,,,,,,,,,,TRUE,,,"Surfaxin (lucinactant) is a synthetic, peptide-containing surfactant indicated for the prevention of respiratory distress syndrome (RDS) in premature infants.","Discovery Laboratories, Inc.",Respiratory Distress Syndrome,6-Mar-12,3/6/12,lucinactant,No,1294,527,0,767,,,,,,,,1,Zioptan,,,,,,,,,,,,,TRUE,,Zioptan (tafluprost ophthalmic solution) is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.,"Merck & Co., Inc.","Glaucoma (Open Angle), Intraocular Hypertension",10-Feb-12,2/10/12,tafluprost ophthalmic solution,No,1816,962,0,854,,,,,,,,1,Kalydeco,,,,,,,,,,,,TRUE,,,Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic fibrosis (CF) in patients ages 6 months and older who have one mutation in the CFTR gene that is responsive to ivacaftor.,Vertex Pharmaceuticals Incorporated,Cystic Fibrosis,31-Jan-12,1/31/12,ivacaftor,No,213,109,104,0,,,,,,,,1,Erivedge,,,,,,,,TRUE,,,,,,,Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell carcinoma (BCC).,Genentech,Basal Cell Carcinoma,30-Jan-12,1/30/12,vismodegib,No,104,104,0,0,,,,,,,,1,Inlyta,,,,,,,,TRUE,,,,,,,Inlyta (axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. ,Pfizer Inc.,Renal Cell Carcinoma,27-Jan-12,1/27/12,axitinib,No,723,361,0,362,,,,,,,,1,Picato,,,,TRUE,,,,,,,,,,,Picato (ingenol mebutate) is an inducer of cell death indicated for the topical treatment of actinic keratosis.,Leo Pharma,Actinic Keratosis,23-Jan-12,1/23/12,ingenol mebutate,No,1005,503,502,0,,,,,,,,1,Voraxaze,,,,,,,,,,,,,,TRUE,Voraxaze (glucarpidase) is a carboxypeptidase enzyme indicated for the treatment of toxic plasma methotrexate levels in patients with delayed methotrexate clearance due to impaired renal function. ,BTG International Inc.,Toxic Methotrexate Levels,17-Jan-12,1/17/12,glucarpidase,No,22,22,0,0,,,,,,,,1,Erwinaze,,,,,,,,TRUE,,,,,,,Erwinaze (asparaginase Erwinia chrysanthemi) is an antineoplastic agent used to treat patients with acute lymphoblastic leukemia (ALL) who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegapargase chemotherapy drugs.,Jazz Pharmaceuticals,Acute Lymphoblastic Leukemia,18-Nov-11,11/18/11,asparaginase Erwinia chrysanthemi,No,35,35,0,0,,,,,,,,2,Eylea,,,,,,,,TRUE,,,,,TRUE,,"Eylea (aflibercept) is a VEGF inhibitor indicated for the treatment of patients with neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy.","Regeneron Pharmaceuticals, Inc.",Macular Degeneration; Macular Edema; Diabetic Retinopathy; Diabetic Macular Edema,18-Nov-11,11/18/11,aflibercept,No,2412,1817,0,595,,,,,,,,1,Jakafi,,,,,,,,TRUE,,,,,,,Jakafi (ruxolitinib) is a Janus kinase (JAK) inhibitor indicated for the treatment of:,Incyte Corporation,"Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease",16-Nov-11,11/16/11,ruxolitinib,No,528,301,154,73,,,,,,,,1,Onfi,,,,,,,,,,TRUE,,,,,Onfi (clobazam) is a benzodiazepine antiepileptic drug for the treatment of patients with Lennox-Gastaut syndrome (LGS).,Lundbeck Inc.,Lennox-Gastaut Syndrome,21-Oct-11,10/21/11,clobazam,No,285,228,57,0,,,,,,,,1,Ferriprox,,,,,,,,,,,,,,TRUE,Ferriprox (deferiprone) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.,ApoPharma Inc.,Hemosiderosis,14-Oct-11,10/14/11,deferiprone,No,224,224,0,0,,,,,,,,1,Xalkori,,,,,,,,TRUE,,,,,,,Xalkori (crizotinib) is an oral anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive or ROS1-positive.,Pfizer Inc.,Non-Small Cell Lung Cancer,26-Aug-11,8/26/11,crizotinib,No,255,255,0,0,,,,,,,,1,Firazyr,,TRUE,,,,,,,,,,,,,Firazyr (icatibant) is a selective B2 bradykinin receptor antagonist indicated for the treatment of acute attacks of hereditary angioedema.,Shire plc,Angioedema,25-Aug-11,8/25/11,icatibant,No,218,144,74,0,,,,,,,,1,Adcetris,,,,,,,,TRUE,,,,,,,"Adcetris (brentuximab vedotin) is a CD30-directed antibody-drug conjugate (ADC) indicated for the treatment of adult patients with:","Seattle Genetics, Inc.","Lymphoma, Hodgkin's Disease, Mycosis Fungoides",19-Aug-11,8/19/11,brentuximab vedotin,No,102,102,0,0,,,,,,,,1,Zelboraf,,,,,,,,TRUE,,,,,,,"Zelboraf (vemurafenib) is a kinase inhibitor indicated for the treatment of patients with metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test, and for the treatment of patients with Erdheim-Chester Disease with BRAF V600 mutation.","Genentech, Inc.",Melanoma -- Metastatic,17-Aug-11,8/17/11,vemurafenib,No,807,469,0,338,,,,,,,,1,Brilinta,,TRUE,,,,,,,,,,,,,Brilinta (ticagrelor) is a P2Y12 platelet inhibitor indicated to reduce the rate of thrombotic cardiovascular events in  patients with acute coronary syndrome.,AstraZeneca,Acute Coronary Syndrome,20-Jul-11,7/20/11,ticagrelor,No,18624,9333,0,9291,,,,,,,,1,Xarelto,,TRUE,,,,,,,,,,,,,Xarelto (rivaroxaban) is a factor Xa inhibitor indicated:,"Janssen Pharmaceuticals, Inc.","Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Prevention of Thromboembolism in Atrial Fibrillation, Coronary Artery Disease, Peripheral Arterial Disease, Deep Vein Thrombosis, Pulmonary Embolism",1-Jul-11,7/1/11,rivaroxaban,No,9011,4487,0,4524,,,,,,,,1,Arcapta,,,,,,,,,,,,TRUE,,,Arcapta (indacaterol inhalation powder) is a long-acting beta2-agonist (LABA) for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). ,Novartis Pharmaceuticals Corp.,Chronic Obstructive Pulmonary Disease,1-Jul-11,7/1/11,indacaterol inhalation powder,No,5451,2770,1289,1392,,,,,,,,1,Nulojix,,,,,,,,TRUE,,,,,,,Nulojix (belatacept) is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant.,Bristol-Myers Squibb Company,Organ Transplant -- Rejection Prophylaxis,15-Jun-11,6/15/11,belatacept,No,1209,804,0,405,,,,,,,,1,Potiga,,,,,,,,,,TRUE,,,,,Potiga (ezogabine) is a potassium channel opener indicated for the adjunctive treatment of adults with partial-onset seizures.,GlaxoSmithKline and Valeant Pharmaceuticals International,Seizures,10-Jun-11,6/10/11,ezogabine,No,1239,817,0,422,,,,,,,,1,Dificid,TRUE,,,,,,,,,,,,,,Dificid (fidaxomicin) is a macrolide antibacterial drug indicated for the treatment of Clostridium difficile-associated diarrhea.,"Optimer Pharmaceuticals, Inc.",Clostridial Infection,27-May-11,5/27/11,fidaxomicin,No,1105,542,0,563,,,,,,,,1,Incivek,,,,,,,TRUE,,,,,,,,"Incivek (telaprevir) is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated, in combination with peginterferon alfa and ribavirin, for the treatment of chronic hepatitis C (CHC).",Vertex Pharmaceuticals Incorporated,Chronic Hepatitis C,23-May-11,5/23/11,telaprevir,No,354,286,0,68,,,,,,,,1,Edurant,,,,,,,TRUE,,,,,,,,Edurant (rilpivirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy (treatment-naí¿ve).,Tibotec Pharmaceuticals,HIV Infection,20-May-11,5/20/11,rilpivirine,No,1368,686,0,682,,,,,,,,1,Victrelis,,,,,,,TRUE,,,,,,,,Victrelis (boceprevir) is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C.,Merck,Chronic Hepatitis C,13-May-11,5/13/11,boceprevir,No,1500,1057,0,443,,,,,,,,1,Tradjenta,TRUE,,,,,,,,,,,,,,Tradjenta (linagliptin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.,Boehringer Ingelheim Pharmaceuticals Inc.,Diabetes Type 2,2-May-11,5/2/11,linagliptin,No,3551,2169,621,761,,,,,,,,1,Zytiga,,,,,,,,TRUE,,,,,,,Zytiga (abiraterone acetate) is a CYP17 inhibitor indicated for the treatment of patients with metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.,Centocor Ortho Biotech Inc.,Prostate Cancer,28-Apr-11,4/28/11,abiraterone acetate,No,1195,797,398,0,,,,,,,,1,Caprelsa,,,,,,,,TRUE,,,,,,,Caprelsa (vandetanib) is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable (non-operable) locally advanced or metastatic disease.,AstraZeneca,Thyroid Cancer,6-Apr-11,4/6/11,vandetanib,No,331,231,0,100,,,,,,,,1,Horizant,,,,,,,,,,TRUE,,,,,Horizant (gabapentin enacarbil) is a  gabapentin prodrug indicated for the once-daily treatment of restless legs syndrome and postherpetic neuralgia.,"GlaxoSmithKline and XenoPort, Inc.","Restless Legs Syndrome, Postherpetic Neuralgia",6-Apr-11,4/6/11,gabapentin enacarbil,No,541,337,204,0,,,,,,,,1,Yervoy,,,,,,,,TRUE,,,,,,,"Yervoy (ipilimumab) is a human cytotoxic T-lymphocyte antigen 4 (CTLA-4)-blocking antibody indicated for the treatment of melanoma. Yervoy is also used in combination with Opdivo (nivolumab) for the treatment of advanced renal cell carcinoma, and microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer.",Bristol-Myers Squibb,"Melanoma -- Metastatic, Renal Cell Carcinoma, Colorectal Cancer",25-Mar-11,3/25/11,ipilimumab,No,676,540,0,136,,,,,,,,1,Benlysta,,,,,,,,TRUE,,,,,,,Benlysta (belimumab) is B-lymphocyte stimulator (BLyS)-specific inhibitor indicated for the treatment of patients with systemic lupus erythematosus.,"Human Genome Sciences, Inc. and GlaxoSmithKline",Systemic Lupus Erythematosus,10-Mar-11,3/10/11,belimumab,No,1684,1122,562,0,,,,,,,,1,Daliresp,,,,,,,,,,,,TRUE,,,Daliresp (roflumilast) is an orally administered phosphodiesterase 4 (PDE4) enzyme inhibitor indicated as a treatment to reduce the risk of COPD  exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.,"Allergan, Inc.",Chronic Obstructive Pulmonary Disease,28-Feb-11,2/28/11,roflumilast,No,9481,5277,4204,0,,,,,,,,1,Edarbi,,,TRUE,,,,,,,,,,,,Edarbi (azilsartan medoxomil) is an angiotensin II receptor blocker (ARB) for the treatment of hypertension.,Takeda Pharmaceutical Company Limited,Hypertension,25-Feb-11,2/25/11,azilsartan medoxomil,No,5941,3672,801,1468,,,,,,,,1,Viibryd,,,,,,,,,,TRUE,,,,,Viibryd (vilazodone) is a dual-acting potent and selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist indicated for the treatment of major depressive disorder (MDD). ,"Allergan, Inc.",Depression,21-Jan-11,1/21/11,vilazodone,No,869,436,433,0,,,,,,,,1,Natroba,,,,,,,,,,,TRUE,,,,Natroba (spinosad) is a pediculicide indicated for the topical treatment of head lice infestations.,ParaPRO LLC,Lice,18-Jan-11,1/18/11,spinosad,No,1038,552,486,0,,,,,,,,1,Xgeva,,,,,,,,,TRUE,,,,,,Xgeva (denosumab) is a RANK ligand (RANKL) inhibitor indicated for the prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors. Xgeva is also indicated for treatment giant cell tumor of bone and for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.,Amgen Inc.,"Osteolytic Bone Metastases of Solid Tumors, Osteolytic Bone Lesions of Multiple Myeloma, Giant Cell Tumor of Bone, Hypercalcemia of Malignancy",18-Nov-10,11/18/10,denosumab,No,7808,3902,3906,0,,,,,,,,1,Halaven,,,,,,,,TRUE,,,,,,,"Halaven (eribulin mesylate) is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer, and liposarcoma.",NA,NA,15-Nov-10,11/15/10,eribulin mesylate,No,762,508,0,254,,,,,,,,1,Egrifta,,,,,,TRUE,,,,,,,,,Egrifta (tesamorelin) is a synthetic analogue of growth hormone releasing factor (GRF) for the treatment of excess abdominal fat in HIV patients with lipodystrophy.,Theratechnologies,Reduction of Excess Abdominal Fat in HIV-Infected Patients with Lipodystrophy,10-Nov-10,11/10/10,tesamorelin,No,806,543,263,0,,,,,,,,1,Teflaro,,,,,,,TRUE,,,,,,,,Teflaro (ceftaroline fosamil) is a cephalosporin antibacterial indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).,"Allergan, Inc.","Pneumonia, Skin and Structure Infection",29-Oct-10,10/29/10,ceftaroline fosamil,No,1105,553,0,552,,,,,,,,1,Latuda,,,,,,,,,,TRUE,,,,,Latuda (lurasidone) is an atypical antipsychotic agent for the treatment of schizophrenia and bipolar depression. ,"Dainippon Sumitomo Pharma America, Inc.","Schizophrenia, Bipolar Disorder",28-Oct-10,10/28/10,lurasidone,No,1260,875,385,0,,,,,,,,1,Pradaxa,,TRUE,,,,,,,,,,,,,Pradaxa (dabigatran etexilate) is a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation; and for the treatment and reduction of risk of deep vein thrombosis and pulmonary embolism.,"Boehringer Ingelheim Pharmaceuticals, Inc.","Prevention of Thromboembolism in Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism",19-Oct-10,10/19/10,dabigatran etexilate,No,18113,12091,6022,0,,,,,,,,1,Gilenya,,,,,,,,TRUE,,,,,,,Gilenya (fingolimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing forms of multiple sclerosis.,Novartis,Multiple Sclerosis,21-Sep-10,9/21/10,fingolimod,No,2554,1701,853,0,,,,,,,,1,Krystexxa,,,,,,,,,TRUE,,,,,,Krystexxa (pegloticase) is a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy.,"Savient Pharmaceuticals, Inc.",Gout,14-Sep-10,9/14/10,pegloticase,No,212,169,43,0,,,,,,,,1,ella,,,,,TRUE,,,,,,,,,,ella is a progesterone agonist/antagonist emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. ,HRA Pharma,Postcoital Contraception,13-Aug-10,8/13/10,NA,No,2930,2086,0,844,,,,,,,,1,Xeomin,,,,,,,,,TRUE,,,,,,"Xeomin (incobotulinumtoxinA) is a botulinum toxin type A for the treatment of cervical dystonia, blepharospasm, glabellar lines, upper limb spasticity, and excessive drooling.","Merz Pharmaceuticals, LLC","Cervical Dystonia, Blepharospasm, Glabellar Lines, Upper Limb Spasticity, Excessive Salivation",30-Jul-10,7/30/10,incobotulinumtoxinA,No,342,234,108,0,,,,,,,,1,Lastacaft,,,,,,,,,,,,,TRUE,,Lastacaft (alcaftadine ophthalmic solution) is a topical H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.,"Allergan, Inc.",Allergic Conjunctivitis,28-Jul-10,7/28/10,alcaftadine ophthalmic solution,No,488,241,247,0,,,,,,,,1,Jevtana,,,,,,,,TRUE,,,,,,,Jevtana (cabazitaxel) is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with hormone-refractory metastatic prostate cancer.,Sanofi-aventis,Prostate Cancer,17-Jun-10,6/17/10,cabazitaxel,No,755,378,0,377,,,,,,,,1,Prolia,,,,,,,,,TRUE,,,,,,"Prolia is a RANK ligand (RANKL) inhibitor indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, for the treatment of bone loss in patients with prostate or breast cancer undergoing hormone ablation therapy, as a treatment to increase bone mass in men with osteoporosis at high risk for fracture, and for the treatment of glucocorticoid-induced osteoporosis in men and women at high risk of fracture. ",Amgen Inc.,Osteoporosis,1-Jun-10,6/1/10,RANKL,No,7393,3702,3691,0,,,,,,,,1,Lumizyme,TRUE,,,,,,,,,,,,,,Lumizyme (alglucosidase alfa) is a lysosomal glycogen-specific enzyme indicated for patients with Pompe disease.,Genzyme Corporation,Pompe disease,24-May-10,5/24/10,alglucosidase alfa,No,90,90,0,0,,,,,,,,1,Natazia,,,,,TRUE,,,,,,,,,,Natazia (dienogest and estradiol valerate) is a combination oral contraceptive indicated for use by women to prevent pregnancy and to treat heavy menstrual bleeding.,Bayer HealthCare Pharmaceuticals Inc.,"Contraception, Heavy Menstrual Bleeding",6-May-10,5/6/10,dienogest and estradiol valerate,No,2665,2266,0,399,,,,,,,,1,Asclera,,,TRUE,,,,,,,,,,,,Asclera (polidocanol) is a sclerosing agent used for the treatment of varicose veins.,Chemische Fabrik Kreussler & Co.,Varicose Vein,30-Mar-10,3/30/10,polidocanol,No,158,105,53,0,,,,,,,,1,Carbaglu,TRUE,,,,,,,,,,,,,,Carbaglu (carglumic acid) is a carbamoyl phosphate synthetase 1 (CPS 1) activator indicated for the treatment of hyperammonemia due to the deficiency of the hepatic enzyme N-acetylglutamate synthase (NAGS). ,Orphan Europe,NAGS Deficiency Hyperammonemia,18-Mar-10,3/18/10,carglumic acid,No,23,23,0,0,,,,,,,,1,VPRIV,TRUE,,,,,,,,,,,,,,VPRIV (velaglucerase alfa) is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy for pediatric and adult patients with Type 1 Gaucher disease.,Shire plc,Gaucher Disease,26-Feb-10,2/26/10,velaglucerase alfa,No,99,82,0,17,,,,,,,,2,Xiaflex,,,,TRUE,,,,,TRUE,,,,,,"Xiaflex (collagenase clostridium histolyticum) is a collagenase product for the treatment of Dupuytren's contracture, a condition that affects the connective tissue that lies beneath the skin in the palm.",BioSpecifics Technologies Corp.,Dupuytren's Contracture,3-Feb-10,2/3/10,collagenase clostridium histolyticum,No,372,248,124,0,,,,,,,,1,Victoza,TRUE,,,,,,,,,,,,,,"Victoza (liraglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in patients 10 years and older with type 2 diabetes mellitus, and to reduce the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.",Novo Nordisk A/S,Diabetes Type 2,25-Jan-10,1/25/10,liraglutide,No,3978,2501,524,953,,,,,,,,1,Ampyra,,,,,,,,,,TRUE,,,,,Ampyra (dalfampridine) is an oral potassium channel blocker indicated to improve walking ability in people with multiple sclerosis.,"Acorda Therapeutics, Inc.",Multiple Sclerosis,22-Jan-10,1/22/10,dalfampridine,No,540,349,191,0,,,,,,,,1,Actemra,,,,,,,,TRUE,,,,,,,Actemra (tocilizumab) is a humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody for the treatment rheumatoid arthritis; systemic juvenile idiopathic arthritis (SJIA); polyarticular juvenile idiopathic arthritis (PJIA); giant cell arteritis; and CAR T cell-induced severe or life-threatening cytokine release syndrome.,"Genentech USA, Inc.","Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Giant Cell Arteritis",8-Jan-10,1/8/10,tocilizumab,No,4087,2635,1168,284,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,